UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

 ☒  Filed by the Registrant        ☐  Filed by a Party other than the Registrant

CHECK THE APPROPRIATE BOX:
☐	Preliminary Proxy Statement
☐	Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒	Definitive Proxy Statement
☐	Definitive Additional Materials
☐	Soliciting Material Under Rule 14a-12

Linde plc

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):
☒	No fee required.
☐	Fee paid previously with preliminary materials:
☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

Making our world more productive

A Message from Our Chairman

Dear fellow shareholders,

On behalf of Linde’s Board of Directors, I am pleased to invite you to the 2026 Annual General Meeting of Shareholders of Linde plc being held in London, UK.

The Linde Board

The Board’s composition reflects a mix of diverse backgrounds, experiences, skills and perspectives that contribute to a strong and well-functioning Board. Each of our nine directors has substantial senior executive experience in areas critical to our business, resulting in meaningful Board oversight of management.

Steve Angel Retirement. Steve Angel retired as Chairman of the Linde Board effective January 31, 2026, after his tenure as Linde plc’s initial CEO and subsequently its second Chairman. We thank Steve for his many contributions to the Board and the Company.

New Board Leadership Structure. The Board routinely evaluates Board leadership succession and the appropriate Board leadership structure for Linde. After Steve Angel informed the Board of his intention to retire, on September 29, 2025, the Board determined that it would be in the best interests of the Company and its shareholders that I be appointed Chairman of the Board while continuing to serve as the Chief Executive Officer effective January 31, 2026. This combined Chairman and CEO role allows me to leverage my knowledge of the Company and the industrial gases industry and lead the Board to focus attention on key strategic matters. The Board also determined that Linde should continue to have a Lead Independent Director to ensure robust oversight by all other directors who are independent, and appointed Robert L. Wood to continue to serve as Linde’s Lead Independent Director. The Board will continue to periodically review the Board leadership structure to ensure that it is in the best interests of the Company and its shareholders.

Board Recruitment. There has been substantial Board refreshement since 2022, as eight directors have retired, and five new directors have joined the Board. The Board continues to focus on recruiting new directors with the background, skills and experience required to contribute to Linde’s future success.

Board and Committee Oversight of Key Matters

The Board and its committees are actively involved in providing oversight and counsel to management regarding numerous areas that are critical to Linde and its shareholders, including the following:

The Audit Committee oversees key accounting and financial matters, including (1) selecting the independent auditor; (2) monitoring the internal audit function and compliance with legal and regulatory requirements; and (3) recommending a capital allocation strategy to the Board.

The Human Capital Committee supervises the executive compensation program, including (1) designing the program to reflect Linde’s pay for performance culture and alignment of shareholders’ and management’s interests; (2) making annual senior executive compensation determinations, including setting challenging annual variable compensation goals, determining payouts based on those goals, and providing long-term stock incentives for executive officers and other eligible employees. It also reviews the safety strategy and progress annually.

The Nomination and Governance Committee oversees selection of Board members, recruitment and refreshment, committee assignments, Board compensation, the Board self-evaluation process, and corporate governance matters generally.

The Sustainability Committee oversees Linde’s programs, policies and practices related to environmental matters, including sustainability goals, decarbonization and clean energy efforts.

The Board’s oversight includes, among others (1) conducting an annual business plan review in January and an annual strategy review in October, in addition to multiple strategic business reviews throughout the year; (2) determining a capital allocation strategy, with a focus on investment for future growth and appropriate shareholder distribution levels. This included 8% and 7% dividend increases in 2025 and 2026, respectively, with 2026 being the 33rd consecutive annual dividend increase, as well as a continuation of Linde’s existing $15 billion share repurchase program; (3) performing an annual enterprise risk assessment; (4) reviewing and approving strategic acquisitions and large capital projects that are a core component of Linde’s growth strategy; and (5) reviewing senior executive talent and management succession planning.

The Board thanks you for your continuing support and confidence in Linde.

Regards,

Sanjiv Lamba

Table of Contents

Notice of 2026 Annual General Meeting of Shareholders	1
Proxy Statement Highlights	3
Proposals	3
2025 Business Performance Highlights	5
Board and Governance Highlights	7
Compensation Highlights	9
Corporate Governance and Board Matters	10
Linde’s Corporate Governance Framework	10
Board Committees	18
Director Compensation	21
Director Nominees	24
Proposal 1: Appointment of Directors	34
Audit Matters	35
Oversight of Independent Auditors	35
Auditor Independence	36
Fees Paid to the Independent Auditor	37
Audit Committee Report	38
Proposal 2a: Non-Binding Ratification of the Appointment of the Independent Auditor	39
Proposal 2b: Authorization of the Board to Determine the Auditor’s Remuneration	39
Executive Compensation Matters	40
Report of the Human Capital Committee	40
Compensation Discussion and Analysis	40
Executive Compensation Tables	52
Table 1: Summary Compensation	52
Table 2: Grants of Plan-Based Awards	54
Table 3: Outstanding Equity Awards at Fiscal Year-End	56
Table 4: Option Exercises and Stock Vested	57
Table 5: Pension Benefits	58
Table 6: Nonqualified Deferred Compensation	62
Severance and Other Change-In Control Benefits	63
Table 7: Amounts Potentially Payable upon Termination	65
Pay Versus Performance	68
CEO Pay Ratio	74
Reconciliation to Compensation and Non-GAAP Measures	75
Proposal 3: Advisory and Non-Binding Vote on Named Executive Officer Compensation	76
Proposal 4: Determination of Price Range for Re-allotment of Treasury Shares	77
Proposal 5: Shareholder Proposal Requesting Renewable Electricity Procurement Strategy Report	78
Information on Share Ownership	81
Information About the Annual General Meeting and Voting	82
General Information	82
Miscellaneous	86

Making our world more productive

Notice of 2026 Annual General Meeting of Shareholders

Dear Shareholder:

The Annual General Meeting (“AGM”) of Shareholders of Linde plc (“Linde” or the “Company”) will be held at 1:00 PM United Kingdom time (8:00 AM Eastern Daylight Time in the U.S.) on Tuesday, July 28, 2026, at the Corinthia Hotel, Whitehall Place, Westminster, London, SW1A 2BD, United Kingdom, for the following purposes:

1.	By separate resolutions, to appoint the nine director nominees described in the proxy statement.
2.	To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.	To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.	To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
5.	To consider and vote on a shareholder proposal requesting a report regarding the Company’s renewable electricity procurement strategy
6.	To conduct such other business as may properly come before the meeting.

This Proxy Statement and a form of proxy are being distributed to shareholders on or about April 29, 2026. Only holders of record of Linde ordinary shares at the close of business on April 28, 2026, will be entitled to receive notice of, and to attend and vote at, the AGM or any adjournment or postponement thereof.

It is important that your shares be represented and voted at the meeting. Any shareholder entitled to attend, speak, ask questions and vote at the meeting, may exercise his or her right to vote by appointing a proxy or proxies to attend and vote on his or her behalf. A shareholder may appoint the persons named in the proxy card provided or another person, who need not be a shareholder of the Company, as a proxy, by electronic means or in writing, to vote some or all of their shares. Appointment of a proxy does not preclude shareholders from attending, speaking and asking questions at the meeting should they subsequently wish to do so. Please note that proxies may be required to provide identification to attend the meeting.

Whether or not you expect to attend the AGM in person, please promptly provide your proxy either online or by telephone, as further explained in the accompanying proxy statement, or by filling in, signing, dating and promptly mailing a proxy card. We recommend that you review the further information on the process for, and deadlines applicable to, voting, attending the meeting and appointing a proxy under “Information About the Annual General Meeting and Voting” of this proxy statement. Please be aware that, if you own shares in a brokerage account, you must instruct your broker on how to vote your shares. Without your instructions, Nasdaq Stock Market rules do not allow your broker to vote your shares on any of the proposals except those identified herein. Please exercise your right as a shareholder to vote on all proposals, including the re-appointment of the director nominees, by instructing your broker by proxy.

Linde plc 1

During the meeting, management will also present, and the auditors will report to shareholders on, our Irish financial statements for the fiscal year ended December 31, 2025. This 2026 Notice of Annual General Meeting and Proxy Statement, the 2025 Form 10-K and Annual Report, the Irish financial statements together with copies of any other documentation relating to the 2026 Annual General Meeting, including forms of proxy, are available on the Linde website (see page 82 of this proxy statement for more details).

By Order of The Board of Directors

Sanjiv Lamba

Chairman of the Board and Chief Executive Officer

April 29, 2026

2 Linde plc

Proxy Statement Highlights

Proposals

Proxy Statement Highlights

This summary highlights selected information in this Proxy Statement. Please review the entire document before voting.

Annual General Meeting of Shareholders of Linde plc

Date	Time	Location	Admission
Tuesday, July 28, 2026	1:00 PM UK time (8:00 AM Eastern Daylight Time in the U.S.)	Corinthia Hotel Whitehall Place Westminster, London SW1A 2BD, U.K.	See “Attending the Annual General Meeting” on page 85 for instructions.

Shareholders may, by technological means, participate in the 2026 Annual General Meeting in Ireland in accordance with section 176 of the Irish Companies Act 2014 by attending the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, DO2 T380, Ireland at the time of the meeting.

Proposals

	Proposal	Board Voting Recommendation	Explanation of Proposal and Reason(s) for Board Recommendations	Further Information (page)
1.	By separate resolutions, to appoint the nine director nominees described in the proxy statement	FOR each nominee	Directors must be elected to the Board annually. Linde’s nominees are seasoned leaders who bring a mix of skills and qualifications to the Board.	34
2.	(a) To ratify, on an advisory and non-binding basis, the appointment of PwC as the independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration	FOR FOR	Based on its recent evaluation, Linde’s Audit Committee believes that the retention of PricewaterhouseCoopers as the Auditor for 2026 is in the best interests of the Company and its shareholders. The Company requests shareholders’ non-binding ratification of the Auditor’s retention and the binding authorization for the Audit Committee to determine the Auditor’s remuneration.	39
3.	To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers as required under SEC rules	FOR	Shareholders must vote annually on whether to approve the compensation paid to Linde’s five most highly compensated executive officers (“Say-On-Pay” vote). Linde’s executive compensation program reflects its commitment to paying for performance. This vote is required under SEC rules.	76
4.	To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.	FOR	The Board has authorized the Company’s share repurchase programs and believes that such programs enhance shareholder value as a means of returning capital to shareholders. Repurchased shares are held as treasury shares until they are either cancelled or used to fund employee and Director stock compensation awards. Irish law requires periodic shareholder approval of the price range at which treasury shares may be re-allotted for these purposes.	77
5.	To consider and vote on a shareholder proposal requesting a report regarding the Company’s renewable electricity procurement strategy	AGAINST	Linde’s sustainability and carbon reduction goals and policies include renewable energy targets and strategies. These, as well as Linde’s current public disclosures, substantially meet what the proposal requests. As such, an additional report is not necessary or useful to shareholders.	78

The required approvals are a majority of votes cast for Proposals 1,2, 3 & 5 and 75% of votes cast for Proposal 4.

Linde plc 3

Proxy Statement Highlights

How to Vote

Your vote is important. You are eligible to vote if you are a shareholder of record as of April 28, 2026. Even if you plan to attend the meeting, please vote as soon as possible using one of the following methods. In all cases, you should have your proxy card in hand.

Your Vote is Important	Online	By Phone	By Mail	In person
	www.proxyvote.com	1-800-690-6903	Fill out your proxy card and submit via mail	Attend in person at the above time and location. Please bring a photo ID.

4 Linde plc

Proxy Statement Highlights

2025 Business Performance Highlights

2025 Business Performance Highlights

2025 Year in Review

In 2025, Linde delivered another year of resilient performance, with operating profit, cash flow, and backlog each exceeding $10 billion. Operating margins expanded to 29.8%, ROC reached 24.2% and EPS grew 6%. These results underscore the strength of our balanced end market portfolio, network density and rigorous capital discipline. Furthermore, we continue making significant investments for rocket propellant to contracted space launch customers which is expected to grow double-digits for the years to come.

In 2025, sales were $34.0 billion, up 3% versus 2024. Compared to prior year, sales increased 3% from 2% price attainment and 1% bolt-on acquisitions, while volumes remained stable. Linde generated strong operating cash flow of $10.4 billion. The Company invested $5.3 billion in capital expenditures and returned $7.4 billion to shareholders in the form of dividends and share buybacks, including an 8% dividend increase which was the 32nd consecutive year of dividend increases. These results are a testament of Linde’s ability to consistently reward its owners under any macro-economic environment.

Financial highlights

· Sales $34.0 billion, up 3%, underlying sales up 2%

· Operating profit(a) $10.1 billion, up 4%

· Operating profit margin(a) 29.8%, up 30 basis points versus prior year

· Earnings per share(a) $16.46, up 6%

· After-tax return on capital(a) reached 24.2%

· Returned $7.4 billion to shareholders through dividends and share repurchases

Business highlights

· Total project backlog of $10 billion

· Major win to supply world-scale low-carbon ammonia facility in Louisiana

· Investments >$400 million in over 20 bolt-on acquisitions globally

· Year-over-year (“YoY”) reduction of absolute GHG emissions, ~2mm mt CO2e

· Low-carbon power consumption, ~50% of total

· Active low-carbon & renewable power; +23% YoY

· Recognition across leading global employer and equity indices, including Forbes Global 2000

· Best in-class safety performance

Returned $7.4 billion to shareholders

•Dividend increased by 8%

•Share repurchases, net of issuances, in the amount of $4.6 billion

(a) Adjusted operating margin, earnings per share and after-tax return on capital are non-GAAP measures. Adjusted operating margin and earnings per share amounts are reconciled to reported amounts in the “Non-GAAP Financial Measures” Section in Item 7 of the Linde plc 2025 Form 10-K. For definition of after-tax return on capital and reconciliation to GAAP please see the “Non-GAAP Measures and Reconciliations” set forth in the financial tables that are included as an appendix to the 4th quarter and full year 2025 earnings press release that was furnished in the Linde plc Form 8-K filed on February 5, 2026.

Linde plc 5

Proxy Statement Highlights

2025 Business Performance Highlights

Linde Stock Performance

The graph below compares the most recent five-year cumulative returns of Linde’s ordinary shares with those of the Standard & Poor’s 500 Index (“SPX”) and the S5 Materials Index (“S5MATR”) which covers 28 companies, including Linde. The figures assume an initial investment of $100 on December 31, 2020 and that all cash dividends have been reinvested into additional shares.

	2020	2021	2022	2023	2024	2025
LIN	$100	$133	$128	$163	$168	$173
SPX	$100	$129	$105	$133	$166	$196
S5MATR	$100	$127	$112	$126	$126	$139

6 Linde plc

Proxy Statement Highlights

Board and Governance Highlights

Board and Governance Highlights

Corporate Governance Highlights

Linde plc has a strong corporate governance structure that compares favorably to that of other large public companies and to the standards of recognized governance organizations. A summary of the key aspects of Linde plc’s corporate governance structure is set forth below, followed by a more detailed discussion of certain governance matters.

Board and Corporate Governance Information
Board Matters		Corporate Governance Matters
Size of Board	9	Limits to service on other Boards for Directors (4 other public company Boards)	Yes
Number of Independent Directors	8 89%	Limits to service on other Boards for CEO (2 other public company Boards)	Yes
Lead Independent Director	Yes	Mandatory Director Retirement Age	75
Board Committees (Audit, Human Capital, Nomination and Governance, Sustainability and Executive)	5	Succession Planning Process Board Risk Oversight	Yes Yes
Number of Regular Board Meetings	5	Proxy Access Shareholders May Call Special Meetings	Yes Yes
Board Composition •Women – 3 •Ethnically/Racially Diverse – 2	33% 22%	Code of Conduct for Directors, Officers and Employees	Yes
Average Director Age	65.7	Stock Ownership Guidelines for Directors and Executive Officers Anti-Hedging and Pledging Policies Clawback Policy Rights Agreement (Poison Pill)	Yes Yes Yes No
Average Director Tenure (Years)	5.8	Annual Election of Directors	Yes
Annual Board and Committee Evaluations	Yes	Majority Voting in Director Elections	Yes

Public Company Legal and Regulatory Framework

Linde plc is incorporated in Ireland and is subject to Irish corporate law pursuant to the Irish Companies Act 2014. In addition, Linde plc ordinary shares are listed and trade on the Nasdaq Stock Market (“Nasdaq”). Linde plc’s primary governance obligations arise from its designation as a domestic issuer for Nasdaq purposes and, as such, the Company is subject to the corporate governance rules of the Nasdaq, requiring it to adopt certain governance policies (which the Company has complied with), and to the reporting and other rules of the United States Securities and Exchange Commission (the “SEC”) requiring it to file Forms 10-K, 10-Q, 8-K, proxy statements and other public company reports.

Linde plc 7

Proxy Statement Highlights

Board and Governance Highlights

Board of Directors and Nominees

The following nine persons currently serve on the Board of Directors and have been nominated for re-appointment to serve until the 2027 annual general meeting of shareholders and the election and qualification of their successors.

Name	Age	Director Since	Background	Independent		Current Committee Memberships (1)	Other Current Public Company Boards
				Yes	No
Sanjiv Lamba	61	2022	Chairman of the Board & Chief Executive Officer of Linde plc; former Chief Operating Officer of Linde plc		X	Chair of EX	•Amphenol Corporation
Prof. DDr. Ann-Kristin Achleitner	60	2018	Scientific Co-Director, Center for Entrepreneurial and Finance Studies, Technical University Munich, Germany	X		Chair of HC, SC	•Lazard Ltd. •Deutsche Post AG (DHL)
Dr. Thomas Enders	67	2018	Former Chief Executive Officer & Member of Executive Committee, Airbus SE	X		Chair of SC, AC, EX	•GE Aerospace
Hugh Grant	67	2023	Former Chief Executive Officer and Chairman of Monsanto Company	X		HC, NG, EX	•Freeport-McMoRan, Inc.
Joe Kaeser	68	2021	Former President and Chief Executive Officer of Siemens AG	X		Chair of NG, HC	•Daimler Truck Holding AG •Siemens Energy AG
Dr. Victoria E. Ossadnik	57	2018	Management Board member and Chief Operating Officer – Digital-E. ON SE	X		AC, NG	•E.ON SE •Münchener Rückversicherungs-Gesellschaft AG
Paula Rosput Reynolds	69	2024	President and CEO, Prefer West LLC	X		AC, SC	•National Grid plc •GE Vernova
Alberto Weisser	70	2021	Former Chairman and Chief Executive Officer of Bunge Limited	X		Chair of AC, SC	•Bayer AG •PepsiCo
Robert L. Wood	72	2018	Lead Independent Director of Linde Plc; Partner, The McChrystal Group; Former Chairman, President & Chief Executive Officer of Chemtura Corporation	X		HC, NG, EX	•None

(1) Committees: AC means Audit Committee; HC means Human Capital Committee; EX means Executive Committee; NG means Nomination and Governance Committee; SC means Sustainability Committee

8 Linde plc

Proxy Statement Highlights

Compensation Highlights

Compensation Highlights

Compensation Philosophy

The Company’s executive compensation programs are designed with the following objectives:

•Pay for performance: Build and support a performance-driven culture in which realized compensation varies with

Company results, with downside risk and upside opportunity.

•Alignment with shareholders: Focus executives on total Company performance in the eye of shareholders, and

reward executives when shareholders are rewarded.

•Competitive with market: Offer pay programs that attract and retain talented executives.

•Weighted toward pay-at-risk: Include a fixed base pay element plus variable short- and long-term incentives.

Elements of Executive Compensation

Element	Form	Key Features
Base Salary	Cash	·  Competitive fixed pay to attract and retain executives. ·  Increases, if applicable, are typically made effective on April 1st of each year.
Annual Variable Compensation	Cash	·  Variable incentive to reward delivery of short-term financial and strategic objectives. ·  Payout determined based on performance against pre-established annual goals. ·  Performance weighting: ·  75% tied to financial performance (Sales, Net Income, Operating Cash Flow). ·  25% tied to non-financial performance (Core Values, Relative Performance & Strategic Positioning, and Greenhouse Gas Emissions). ·  Final payout reflects achievement against Variable Compensation goals, adjusted by an Individual Performance Factor (0.00 - 1.25), excluding the CEO.
Equity Awards	Performance Share Units (50%)	·  Performance measured equally on Return on Capital (ROC) and Relative Total Shareholder Return (TSR). ·  Vest on the third anniversary of the grant date, subject to achievement against pre-established goals.
	Stock Options (30%)	·  Vest in equal installments on the first, second and third anniversaries of the grant date. ·  Expire on the tenth anniversary of the grant date.
	Restricted Stock Units (20%)	·  Vest on the third anniversary of the grant date.

Best Practices Supporting Executive Compensation Objectives

Linde plc 9

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Corporate Governance and

Board Matters

Linde’s Corporate Governance Framework

Linde operates under Corporate Governance Guidelines which are posted at Linde’s public website, www.linde.com in the About Us/Corporate Governance section. Consistent with those guidelines, the charters of the various Board committees and Linde’s Constitution, the Board has adopted the following policies and practices, among others:

Director Independence

The Board has adopted independence standards for service on Linde’s Board of Directors which are posted at Linde’s public website referenced above. The Board has applied these standards to all the directors and has determined that each qualifies as independent, except Mr. Lamba, the Company’s Chairman of the Board and Chief Executive Officer. The Board is not otherwise aware of any relationship with the Company or its management that could potentially impair the independent judgment of these directors. See also related information in this Proxy Statement under the caption “Certain Relationships and Transactions.”

Board Leadership

In General

Linde’s Corporate Governance Guidelines provide the Board with flexibility to determine the appropriate Board leadership structure from time to time. The Nomination and Governance Committee (consisting entirely of independent directors) regularly reviews the leadership structure, and considers many factors, including the specific needs of Linde and its businesses, corporate governance best practices, shareholder feedback and succession planning, as different structures may be appropriate in different circumstances. The Corporate Governance Guidelines also provide that the Board: (a) shall select a Chairman of the Board and determine his/her duties and responsibilities; and (b) if the Chairman of the Board has not been determined to be independent in accordance with the Board’s independence standards and those of the Nasdaq Stock Exchange and applicable law, then the Board may appoint a Lead Independent Director who has been determined to be independent under such standards and determine his/her responsibilities.

In September 2025, Stephen Angel announced that he would retire as Chairman of Linde’s Board of Directors effective January 31, 2026. The Nomination and Governance Committee considered various alternatives for the Board’s leadership structure and determined that a combined Chairman and CEO would be effective and appropriate and the Board therefore elected Sanjiv Lamba, Linde’s CEO, as the Chairman of the Board effective January 31, 2026 The Board believes that the substantive duties of the Chairman, including calling and organizing meetings and preparing agendas, are best performed by someone having day-to-day familiarity with the business issues confronting the Company and an understanding of the specific areas in which management seeks advice and counsel from the Board.

The Board also determined that it should continue to have a Lead Independent Director to ensure effective independence of the Board’s oversight of management. Therefore, the Board determined that Robert L. Wood, who has served as the Lead Independent Director since March 1, 2022, would continue in this role after Mr. Lamba became the Chairman of the Board. The Board believes this leadership structure is effective and appropriate and in the best interests of Linde and its shareholders. With Mr. Lamba as Chairman of the Board, Linde continues to leverage his significant industry expertise, CEO experience and effective working relationship with the Board to lead the Board and focus its attention on strategic matters and facilitate effective communication between the Board and management. As the Lead Independent Director with clearly defined responsibilities, Mr. Wood ensures robust independent oversight of the Company by the Board.

10 Linde plc

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Chairman of the Board Responsibilities

The designated responsibilities of the Chairman are set forth in the Board’s Corporate Governance Guidelines and include, among others:

•Serving as chairman of the meetings of the Board (other than meetings solely of the independent directors);

•Having the authority to call meetings of the Board;

•Serving as a liaison between the Board and management;

•Being available to consult with management about the concerns of the Board;

•Approving the Board meeting agendas and related information sent to the Board;

•Approving the Board meeting schedules to assure that there is sufficient time for discussion of all agenda items; and

•Being available for consultation and direct communication with major shareholders if requested.

Lead Independent Director Responsibilities

The roles and responsibilities of the Lead Independent Director will be determined by the Board periodically and reviewed at least annually. It is the Board’s current policy that such duties include, among others, the following:

•Providing advice and assistance to the Chairman, as requested;

•Consulting on and approving, in consultation with the Chairman, the agendas for and the scheduling of meetings of the Board;

•Chairing private sessions of the Independent Directors as may be held from time to time

•Chairing meetings of the Board in the absence of the Chairman;

•Serving as a liaison between the Chairman and the Independent Directors;

•Reviewing in consultation with the Chairman, the quality, quantity, appropriateness, and timeliness of information provided to the Board; and

•Communicating with shareholders and other stakeholders in consultation with the Chairman and Chief Executive Officer.

Board Role in Risk Oversight

At least annually, the Board reviews the Company’s risk identification, assessment and management processes and the guidelines and policies by which key risks are managed. As part of that review, the Board discusses (1) the key enterprise risks that management has identified, (2) management accountability for managing or mitigating each risk, (3) the steps being taken to manage each risk, and (4) which Board Committees will oversee each risk area on an ongoing basis.

The risk factors disclosed in Item 1A of the Company’s Form 10-K and Annual Report illustrate the range of the risks faced by a global industrial company and help explain the need for strong Board Committee oversight of the management of risks in specific subject areas. Each Committee’s calendar of recurring meeting agenda topics addresses risk areas pertinent to the Committee’s subject-matter responsibilities. These areas include: financing and currency exchange risks (Audit Committee); compensation risks, and executive development and retention (Human Capital Committee);

regular review of the Board’s governance practices (Nomination and Governance Committee); internal controls, investigations, and integrity standards compliance (Audit Committee); and risks related to climate change (Sustainability Committee). Other risk areas are regularly reviewed by the full Board. These include: safety (covered at each Board meeting), economic, market and competitive risk (part of business operating reports at Board meetings, and the annual operating and strategic reviews), geopolitical risks, cyber security, and global compliance risks (supplementing reporting within the Audit Committee). In addition, risk identification and assessment is integrated into Board decision-making with respect to capital projects and acquisitions, entry into new markets, financings, and cash flow analysis, among other matters. In Committee meetings and full Board deliberations, each director brings his or her particular operating, financial, management development, and other experiences and expertise to bear in assessing management’s response to specific risks and in providing advice and counsel with respect to risk mitigation and management.

Linde plc 11

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Board Oversight of Business Strategy

Each year, the Board conducts a comprehensive long-term strategic review of the Company’s outlook and business plans and provides advice and counsel to management regarding the Company’s strategic issues. This process involves engagement by all Board members and senior management. The Board performs a detailed review of management’s proposed strategy for

each of the key business units, which is designed to drive profitable growth over the near-and long-term independent of the macro environment and drive long-term shareholder value creation. Additionally, the board conducts reviews of key strategic issues or initiatives throughout the year.

Board Effectiveness Assessment

The Board assesses its effectiveness annually under a process determined by the Nomination and Governance Committee. Typically, this assessment includes each non-management director completing written questionnaires that are used to evaluate the Board’s effectiveness in the areas of Performance of Core Responsibilities, Decision-Making Support, the Quality of Deliberations, Director Performance, and Committee Functions, as well as consideration of additional Board practices and policies recommended as best practices by recognized governance authorities. Similarly, each Committee annually assesses its effectiveness in meeting its oversight responsibilities under its charter from the Board. The Nomination and Governance Committee reviews the results of the written

assessments, provides the results to all Board members, and the Lead Independent Director may conduct a discussion of the results in an executive session of the non-management directors. Subsequently, the Nomination and Governance Committee may recommend certain actions be taken to enhance the operations and effectiveness of the Board and its committees.

The Nomination and Governance Committee conducted the assessment process in 2025. The results were very favorable, and the Committee concluded that the Board and its committees are functioning properly and efficiently and are performing the core responsibilities of the Board generally and that the committees are meeting their key charter responsibilities.

Director Orientation and Education

New Directors who join Linde’s Board of Directors participate in a comprehensive director orientation program that involves a review of information developed to present foundational knowledge about Linde. Orientation materials typically include information on Linde’s business, industry and strategy, organizational structure, management responsibility, director responsibilities, Board and committee structure and policies, safety, sustainability, risk management, controls, compliance, regulatory landscape, and technology topics. In addition, new directors may also visit Linde operating plants and/or offices.

In addition, the Board is presented with ongoing education in order to increase directors’ familiarity with

Linde’s business, industry developments and emerging issues. Such content may be prepared for the entire board or for a specific committee and include presentations from Linde management and/or outside experts. Typical recurring topics include executive compensation trends, corporate governance and public company regulatory trends, cybersecurity, sustainability, risk, and regulatory developments. Periodically, board members also may convene at Linde sites or have opportunities to participate in technology demonstrations. Directors may also participate in third-party-supplied continuing education, for which Linde reimburses the directors for expenses.

Governance Practices Review

In addition to leading the annual Board and Committee effectiveness assessment referred to above, the Nomination and Governance Committee annually reviews the Company’s governance practices (which may include an outside expert) and updates those practices as it deems appropriate. The Committee

considers, among other things, the results of the Board and Committee effectiveness assessments, developments in Irish company law, federal laws and regulations promulgated by the SEC, and the views and standards of recognized governance authorities and institutional investors

12 Linde plc

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Succession Planning and Personnel Development

In addition to periodic senior management talent and succession reviews conducted by the Board, the Human Capital Committee conducts an annual Succession Planning and Personnel Development session to which all Board members are invited and at which executives are evaluated with respect to their potential for

promotion into senior leadership positions, including that of the CEO. In addition, a variety of executives are introduced to the Board by way of Board and Committee presentations, and directors have unrestricted access to a broad cross-section of managers and high potential employees.

Mandatory Director Retirement

The Board’s policy is that a director who has attained the age of 75 may not stand for re-election at the next annual shareholders’ meeting.

Limits to Service on Other Boards

The Board’s policy is that a non-management director may not serve on more than four additional public company boards, and the CEO may not serve on more than two additional public company boards. Also, a member of the Audit Committee may not serve on more than two additional public company audit committees

unless the Board determines that such a simultaneous service would not impair the ability of such member to effectively serve on the Audit Committee. If the Board so determines, it will disclose such determination in the Company’s annual proxy statement.

Shareholder Outreach and Communications with the Board

The Company has a robust shareholder outreach program which ensures that the Board and management remain responsive to shareholder concerns. This includes ongoing interaction between Investor Relations and major institutional investors, as well as an extensive shareholder outreach program that is conducted annually. In addition, the Board has established procedures to enable a shareholder or other interested

party to direct a communication to the Board of Directors. Such communications may be confidential or anonymous and may be communicated by mail, e-mail, or telephone. Information on how to submit communications, and how they will be handled, is included at www.linde.com in the About Us/ Corporate Governance section.

Director Attendance at Board and Committee Meetings and the Annual Shareholders Meeting

Absent extenuating circumstances, each member of the Board is expected to attend all meetings of the Board, all meetings of each Committee of which he or she is a member, and the Annual General Meeting of Shareholders. Director meeting attendance is one of the factors that the Nomination and Governance Committee

considers in determining whether to re-nominate an incumbent director for election at the Annual General Meeting.

All members of the Board attended the 2025 AGM.

Business Integrity and Ethics

Linde’s Board of Directors has adopted a Code of Business Integrity that is posted on Linde’s public website at https://www.linde.com/about-us/corporate-values and is available in print to any

shareholder who requests it. This Code of Business Integrity applies to Linde’s directors and to all employees, including Linde’s CEO, COO, CFO, Chief Accounting Officer and other officers.

Linde plc 13

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Director Election by Majority Vote and Resignation Policy

Linde’s Constitution requires directors to be elected annually and that a director nominee must receive a majority of the votes cast at an annual general meeting in order to be elected (meaning a greater number of “for” votes than “against” votes) in an uncontested election of directors. The Board’s Tenure and Resignation Policy requires that any director nominee who is then serving as a director must tender his or her resignation if he or she fails to receive this majority vote. The Nomination and Governance Committee of the Board would then consider the resignation offer and recommend to the Board whether to accept or reject the resignation, or whether other action should be taken. The Board would take action on the Committee’s recommendation within 90 days following certification of the vote, and promptly thereafter publicly disclose its decision and the reasons therefor.

Proxy Access

Linde’s Constitution provides that a shareholder, or a group of up to 20 shareholders, who have owned at least 3% of the Company’s outstanding ordinary shares continually for at least three years, may nominate persons for election as directors and have these

nominees included in the Company’s proxy statement. The shareholders or group must meet the requirements in the Company’s Constitution. The number of nominees is generally limited to the greater of two persons or 20% of the number of directors serving on the Board.

Shareholder Rights Agreements

The Company does not have a Shareholder Protection Rights Agreement (sometimes referred to as a “Poison Pill”). Irish law does not expressly prohibit companies from issuing share purchase rights or adopting a shareholder rights plan as an anti-takeover measure. However, there is no directly relevant case law on the validity of such plans under Irish law, and shareholder approval may be required under Irish law to implement such a plan. As Linde plc is an Irish public company with securities admitted to trading on the Nasdaq Stock

Market, it is subject to the Irish Takeover Panel Act, 1997 Takeover Rules 2022, which govern certain aspects of the manner in which a takeover offer can be made for shares in Linde plc. If an offer has been made or is deemed to be imminent, Linde plc is prevented from engaging in frustrating action. The adoption of a shareholder rights agreement would constitute frustrating action, meaning that it could only be adopted on a “clear day” where no such offer is anticipated.

Extraordinary General Meetings of Shareholders

Irish law currently provides that shareholders holding 10% or more of the total voting rights may request that the directors call an extraordinary general meeting at any time. The shareholders who wish to request an extraordinary general meeting must deliver to Linde’s principal executive office a written notice, signed by the shareholders requesting the meeting and stating the purposes of the meeting. If the directors do not, within 21 days of the date of delivery of the request, proceed to convene a meeting to be held within two months of that

date, those shareholders (or any of them representing more than half of the total voting rights of all of them) may themselves convene a meeting, but any meeting so convened cannot be held after the expiration of three months from the date of delivery of the request. These provisions of Irish law are in addition to, and separate from, the requirements that a shareholder must meet in order to have a proposal included in the proxy statement under the rules of the SEC.

Director Stock Ownership Guidelines

The Board’s policy is that non-management directors must acquire and hold the Company’s ordinary shares equal in value to at least five times the annual base compensation retainer awarded in the form of equity or equity-based awards. Directors have five years from

their initial election to meet this guideline. All non-management directors have met this guideline or are within the five-year transition period afforded to them to do so. See the section titled “Information on Share Ownership” in this Proxy Statement.

14 Linde plc

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Executive Stock Ownership and Shareholding Policy

The Board believes that it is important for executive officers to acquire a substantial ownership position in Linde. In this way, their interests are more closely aligned with those of shareholders. Significant stock ownership ensures that executives manage Linde as equity owners.

Accordingly, a stock ownership and shareholding policy has been established for the Company’s executive officers that requires them to own a minimum number of ordinary shares equal or greater in value to a multiple of their base salary, as set forth below. Individuals must meet the applicable ownership level within five years after first becoming subject to the guidelines by acquiring at least 20% of the required level of stock ownership each year. Until the stock ownership requirement is met, executive officers (i) may not sell, transfer or otherwise dispose of any of their Linde ordinary shares and (ii) must retain and hold all Linde ordinary shares acquired from all equity incentive awards, net of shares withheld for taxes and option exercise prices, including performance share unit awards, restricted stock unit awards and stock options.

Set forth below is the stock ownership required by the policy expressed as a multiple of base salary for eachexecutive officer position. As of the date of this Proxy Statement, all covered individuals are in compliance with this policy. Stock ownership of the Named Executive Officers can be found in the table presented under the section titled “Information on Share Ownership.”

	Share ownership as a multiple of base salary
Chief Executive Officer	6X
Chief Financial Officer	3X
Other Executive Officers	3X

Hedging, Pledging and Similar Transactions Prohibited.

The purpose of the Director and Executive Stock Ownership Policies is to ensure that directors and executive leaders will have a meaningful ownership stake in Linde so that their interests will be aligned with shareholder interests. Any investment activities intended to reduce or eliminate the economic risk that ordinarily accompanies such ownership would defeat this purpose. Therefore, directors and executive leaders may not engage in hedging transactions related to Linde’s stock that would have the effect of reducing the economic risk of their holding Linde stock. This prohibition applies to

any Linde stock that a director or executive leader beneficially owns, regardless of whether he/she has fulfilled all or any part of the total stock ownership requirement as set forth above. For example, a director or executive leader may not purchase a “put option” on Linde stock or on certain derivative market instruments of which Linde is a significant component (more than 5%).

Directors and executive leaders also may not pledge or otherwise encumber Linde stock that they own.

Review, Approval or Ratification of Transactions with Related Persons

The Company’s Code of Business Integrity (“Ethics Policy”) prohibits employees, officers and Board members from having a personal, financial or family interest that could in any way prevent the individual from acting in the best interests of the Company (a “conflict of interest”) and provides that any conflict of interest waiver relating to Board members or executive officers may be made only after review and approval by the Board upon the recommendation of its Audit Committee. In addition, the Board’s Corporate Governance Guidelines require that any “related party transaction” by an executive officer or director be pre-approved by a committee of independent and disinterested directors. For this purpose, a “related party transaction” means any transaction or relationship that is reportable under Regulation S-K, Item 404, of the Securities and Exchange Commission (“SEC”) or that, in the case of a non-management director, would violate the Board’s independence standards.

Reporting and review procedures. To implement the foregoing policies, the Audit Committee has adopted a written procedure for the Handling of Potential Conflicts of Interests which specifies a process for the referral of potential conflicts of interests to the Board and standards for the Board’s evaluation of those matters. This policy applies to any transaction or relationship involving an executive officer, a member of the Board of Directors, a nominee for election as a director of the Company, or a family member of any of the foregoing which (1) could violate the Company’s Ethics Policy provisions regarding conflicts of interest, (2) would be reportable under the

Linde plc 15

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

SEC’s disclosure rules, or (3) in the case of a non-management director, would violate the Board’s independence standards.

Under this procedure, potential conflicts of interest are reported to the Company Secretary for preliminary analysis to determine whether referral to the Audit Committee is appropriate. Potential conflicts of interest can be self-identified by the director or executive officer or may arise from internal audits, the integrity hotline or other referrals, or through periodic due diligence conducted by the Company Secretary’s office. The Audit Committee then examines the facts and circumstances of each matter referred to it and makes a final determination as to (1) whether the transaction or relationship would (or does) constitute a violation of the conflicts of interest provisions of the Company’s Ethics Policy, and (2) whether the transaction or relationship should be approved or ratified and the conditions, if any, of such approval or ratification. In determining whether a transaction or relationship constitutes a violation of the conflicts of interest provisions of the Company’s Ethics Policy, the Audit Committee considers, among other factors, the materiality of the transaction or relationship to the individual’s personal interest, whether the individual’s personal interest is materially adverse to or

competitive with the interests of the Company, and whether the transaction or relationship materially interferes with the proper performance of the individual’s duties or loyalty to the Company. In determining whether to approve or ratify a transaction or relationship, the Audit Committee considers, among other factors, whether the matter would constitute a violation of the conflicts of interest provisions of the Company’s Ethics Policy, whether the matter would violate the Nasdaq listing standards, the expected practical impact of the transaction or relationship on the individual’s independence of judgment or ability to act in the best interests of the Company, the availability, practicality and effectiveness of mitigating controls or safeguards such as recusal, restricted access to information, reassignment etc., and the best interests of the Company and its shareholders generally.

Application of Policies & Procedures. During 2025, no actual or potential conflicts of interest were identified with respect to the executive officers and directors of the Company.

Certain Relationships and Transactions

When determining whether any director or nominee is independent, the Board considers all facts and circumstances and any relationships that a director or nominee may have with the Company, directly or indirectly, other than in the capacity of serving as a director. To assist the Board in making independence determinations, it also applies the independence standards which are posted at Linde’s public website, www.linde.com in the About Us/Corporate Governance section. In February 2026, the Board considered the following circumstances and relationships of those directors and nominees who then had any direct or indirect relationship with the Company.

In the ordinary course of its business, Linde sells industrial gases to, and purchases certain goods or services from, E. ON SE, of which Dr. Victoria Ossadnik is an executive officer. The 2025 consolidated revenues for each of Linde and E.ON SE were $34.0 billion and €78.7 billion, respectively. For the 2023, 2024 and 2025 fiscal years, the dollar value of Linde’s sales to, or purchases from, E.ON SE were $0.7 million, $0.4 million and $0.2 million in sales, respectively and $1.0 million, $0.9 million and $1.2 million of purchases, respectively. Such sale and purchase transactions were well below the limits set forth in the Board’s independence standards and were significantly less than 1% of the consolidated revenues of Linde or E.ON SE. Therefore, the Board has determined that such ordinary course business relationships are not material and do not otherwise impair the ability of Dr. Ossadnik to exercise independent judgment as a director.

Insider Trading Policy and Procedures

Linde has adopted an insider trading policy and has additional trading procedures that cover the purchase, sale and other transactions in Company securities by the Company’s directors, officers, and employees, and other covered persons, as well as the Company itself. Linde believes these are reasonably designed to promote compliance with insider trading laws, rules and regulations and applicable exchange listing standards. A copy of our insider trading policy was filed as Exhibit 19 to our Annual Report on Form10-K for the year ended December 31, 2025.

16 Linde plc

Corporate Governance and Board Matters

Linde’s Corporate Governance Framework

Delinquent Section 16(a) Reports

Based solely upon a review of SEC Forms 3, 4 and 5 furnished to the Company and written representations from the Company’s executive officers and directors, the

Company believes that those persons complied with all Section 16(a) filing requirements during 2025 with respect to transactions in the Company’s stock.

Director & Nominee Selection Criteria

The Nomination and Governance Committee will consider any candidate for election to the Board who is timely recommended by a shareholder and whose recommendation otherwise complies with the requirements under Linde’s Constitution. Recommendations should be sent to the Company Secretary of Linde and should include the candidate’s name and qualifications and a statement from the candidate that he or she consents to being named in the proxy statement and will serve as a director if elected. In order for any candidate to be considered by the Nomination and Governance Committee and, if nominated, to be included in the proxy statement, such recommendations must be received by the Company Secretary on or before the date specified in this Proxy Statement under the caption “Shareholder Proposals, Director Nominations and Other Business for the 2027 Annual General Meeting.”

The qualities and skills sought in director nominees are governed by the projected needs of the Board at the time the Nomination and Governance Committee considers adding a new director or renominating incumbent directors. Consistent with the board’s corporate Governance Guidelines, the Committee seeks to build and maintain a Board that contains a range of experiences, competencies, and perspectives that is well-suited for advice and counsel to, and oversight of, the Company’s business and operations. In doing so, the Committee takes into account a variety of factors, including: (1) the Company’s strategies and its market, geographic and regulatory environments, both current and projected, (2) the mix of experiences, competencies, and perspectives (including gender, ethnic and cultural diversity) currently represented on the Board, (3) the results of the Board’s annual self-assessment process, (4) the CEO’s views as to areas in which management would like to have additional advice and counsel from the Board, and (5) with respect to the incumbent directors, meeting attendance, participation and contribution, and the director’s current independence status.

The Committee also seeks in each director candidate a breadth of experience and background that (a) will allow the director to contribute to the full range of issues confronting a global industrial company and (b) will qualify the director to serve on, and contribute to, any of the Board’s standing committees. In addition, the Nomination and Governance Committee believes that every director nominee should demonstrate a strong record of integrity and ethical conduct, an absence of conflicts that might interfere with the exercise of his or her independent judgment, and a willingness and ability to represent all shareholders of the Company.

When the need to recruit a director arises, the Nomination and Governance Committee will consult the Chairman & CEO and other directors, and may engage third party recruiting firms to identify potential candidates. The candidate evaluation process may include inquiries as to the candidate’s reputation and background, examination of the candidate’s experiences and skills in relation to the Board’s needs at the time, consideration of the candidate’s independence as measured by the Board’s independence standards, and other considerations that the Nomination and Governance Committee deems appropriate at the time. Prior to formal consideration by the Nomination and Governance Committee, any candidate who passes such screening would be interviewed by the Nomination and Governance Committee or its Chairman and by the Chairman of the Board & CEO.

Additional information about the specific skills, qualifications and backgrounds of each of the director nominees is set forth in this Proxy Statement under the caption “Director Nominees.”

Proxy Access Nominees. The foregoing description applies only to the Nomination and Governance Committee’s consideration of director nominees who may be nominated by the Committee itself. It does not apply to persons nominated by eligible shareholders under the Company’s Proxy Access structure which has separate requirements that are set forth in Linde’s Constitution.

Linde plc 17

Corporate Governance and Board Matters

Board Committees

Board Committees

The Board currently has five standing committees as described below and each is comprised of only independent directors except for the Executive Committee of which the Chairman of the Board & CEO is a member. The Charters for each of these committees may be found on Linde’s public website, www.linde.com, in the About Us/Corporate Governance section.

Board Director	Audit Committee	Human Capital Committee	Executive Committee	Nomination and Governance Committee	Sustainability Committee
Sanjiv Lamba (Chief Executive Officer)			Chair
Prof. DDr. Ann-Kristin Achleitner		Chair			•
Dr. Thomas Enders	•		•		Chair
Hugh Grant		•	•	•
Joe Kaeser		•		Chair
Dr. Victoria E. Ossadnik	•			•
Paula Rosput Reynolds	•				•
Alberto Weisser	Chair				•
Robert L. Wood		•	•	•

Description of Key Committee Functions

Audit Committee

Committee Chair Alberto Weisser Current Members: Dr. Thomas Enders Dr. Victoria E. Ossadnik Paula Rosput Reynolds Meetings in 2025 5 The Audit Committee assists the Board in its oversight of (a) the independence, qualifications and performance of Linde’s independent auditor, (b) the integrity of Linde’s financial statements, (c) the performance of Linde’s internal audit function, and (d) Linde’s compliance with legal and regulatory requirements. In furtherance of these responsibilities, the Audit Committee, among other duties: (1)appoints the independent auditor to audit Linde’s financial statements, approves the fees and terms of such engagement, approves any non-audit engagements of the independent auditor, and meets regularly with, and receives various reports from, the independent auditor. The independent auditor reports directly to the Audit Committee; (2)reviews Linde’s principal policies for accounting and financial reporting and its disclosure controls and processes, and reviews, with management and the independent auditor, Linde’s financial statements prior to their publication; (3)reviews assessments of Linde’s internal controls, the performance of the Internal Audit function, the performance evaluations of the General Auditor and the Chief Compliance Officer, and the guidelines and policies by which Linde undertakes risk assessment and risk management; (4)reviews the effectiveness of Linde’s compliance, business conduct, integrity and ethics programs; and (5)reviews Linde’s information systems security, focusing on cybersecurity, new technologies such as artificial intelligence, data privacy, and technology infrastructure resiliency.

18 Linde plc

Corporate Governance and Board Matters

Board Committees

Human Capital Committee

Committee Chair Prof. DDr. Ann- Kristin Achleitner Current Members: Hugh Grant Joe Kaeser Robert L. Wood Meetings in 2025 5 The Human Capital Committee assists the Board in its oversight of (a) Linde’s compensation and incentive policies and programs, and (b) management development and succession, in both cases particularly as they apply to Linde’s executive officers. In furtherance of these responsibilities, the Human Capital Committee, among other duties: (1)determines Linde’s policies relating to the compensation of executive officers and assesses the competitiveness and appropriateness of their compensation and benefits; (2)determines the salaries, performance-based variable compensation, equity awards, terms of employment, retirement or severance, benefits, and perquisites of executive officers; (3)establishes the corporate goals relevant to the CEO’s compensation, evaluates the CEO’s performance in light of these goals and sets the CEO’s compensation accordingly; (4)reviews management’s long-range planning for executive development and succession, and develops a CEO succession plan; (5)assesses the design, administration and risk associated with Linde’s management incentive compensation and equity compensation plans; and (6)evaluates periodically the Company’s policies, objectives, and programs related to employee safety, inclusion, artificial intelligence relating to human capital, global giving and community engagement.

Certain Committee Processes for Determining Executive Compensation

Delegation and CEO Involvement. Except under limited circumstances, the Human Capital Committee may not delegate its executive compensation authority to any other persons. With respect to the allocation of compensation and awards to employees other than the executive officers, the Human Capital Committee may, and has, delegated authority to the CEO, subject to guidelines established by the Human Capital Committee. The CEO does not determine the compensation of any of the executive officers, but he does offer for the Human Capital Committee’s consideration his views on relevant matters, as described in more detail in this Proxy Statement in the CD&A section.

Compensation Risk Analysis. The Human Capital Committee considers whether the Company’s compensation policies and practices create incentives for risk-taking that could have a material adverse effect on the Company. Each year, the Human Capital Committee examines management’s review of the Company’s incentive compensation programs applicable to all employees, including executive officers, in order to

evaluate whether they encourage excessive risk-taking through either the design of the executive and management incentive programs, or operational decision-making that could affect compensation payouts. The Human Capital Committee determines if (1) there exists sufficient operational controls, checks and balances that prevent or constrain compensation-driven decision-making that is inappropriate or excessively risky including, among others, frequent risk discussions with the Board, particularly in connection with capital project or acquisition proposals, (2) the Company uses highly leveraged short-term incentives that would tend to drive high short-term risk decisions or unsustainable gains, and (3) the Company’s executive stock ownership policy and the “clawback” policy described in the CD&A also serve as disincentives for unacceptable risk-taking.

A more detailed description of how the Human Capital Committee considers and determines executive compensation is described in this Proxy Statement in the CD&A section.

Linde plc 19

Corporate Governance and Board Matters

Board Committees

Executive Committee

Committee Chair Sanjiv Lamba  Current Members: Dr. Thomas Enders Hugh Grant Robert L. Wood Meetings in 2025 1 The purpose of the Executive Committee is primarily to act on behalf of the entire Board with respect to certain matters that may arise in between regularly scheduled Board meetings, and act on certain other matters from time to time. In particular, the Executive Committee duties include, among others: (1)evaluating and approving any investments, acquisitions, partnerships or divestments requiring Board approval, that are within value thresholds specified by the Board; (2)evaluating and approving any financing or other capital markets transactions requiring Board approval, that are within value thresholds specified by the Board; and (3)acting upon any other such matters within the competencies of the Board, that are not reserved solely to the Board, that are within value thresholds specified by the Board and, in the opinion of the Chairman of the Board, should not be postponed until the next regularly scheduled Board meeting.

Nomination and Governance Committee

Committee Chair Joe Kaeser Current Members: Hugh Grant Dr.Victoria E.Ossadnik Robert L. Wood Meetings in 2025 5 The Nomination and Governance Committee assists the Board in its oversight of (a) the selection, qualifications, compensation and performance of Linde’s directors, (b) Linde’s governance, including the practices and effectiveness of the Board, and (c) various important public policy concerns that affect the Company. In furtherance of these responsibilities, the Nomination and Governance Committee, among other duties: (1)recommends to the Board nominees for election as directors, and periodically reviews potential candidates; (2)reviews policies with respect to the composition, compensation, organization and practices of the Board, and developments in corporate governance matters generally; and (3)reviews Linde’s policies and responses to broad public policy issues such as social responsibility, corporate citizenship, government affairs and legislative issues, and important shareholder issues, including management and shareholder proposals offered for shareholder approval.

Sustainability Committee

Committee Chair Dr. Thomas Enders Current Members: Prof. DDr. Ann-Kristin Achleitner Paula Rosput Reynolds Alberto Weisser Meetings in 2025 3 The Sustainability Committee assists the Board with its oversight of the Company’s programs, policies, practices and strategies related to environmental matters generally, including: (1)The Company’s environmental sustainability goals, including those related to climate change and greenhouse gas emissions, and the Company’s Sustainability Report. (2)the Company’s decarbonization efforts, including those related to the reduction of greenhouse gas emissions from operations; (3)the Company’s clean energy efforts, including those related to clean hydrogen as well as technology and innovation for decarbonization solutions; and (4)sustainable productivity, water conservation and management, energy consumption, product stewardship and zero waste sites.

20 Linde plc

Corporate Governance and Board Matters

Director Compensation

Director Compensation

Director Compensation Program

The Board adopted its Director Compensation Program based in part on an extensive director compensation study and analysis performed by F. W. Cook, a recognized expert compensation consultant. This report included data, analysis and advice, a report on director compensation trends and benchmarking of director compensation against groups of large U.S. and European public companies.

The Company paid the amounts reported in the 2025 Director Compensation table below pursuant to its Director Compensation Program in effect for 2025. The Company does not pay any director who is a Company employee (Mr. Lamba in 2025) for serving as a member of the Board of Directors or any committee of the Board of Directors. The Nomination and Governance Committee of the Board determines non-management director compensation consistent with the Directors’ Compensation principles set forth in the Corporate Governance Guidelines. The Director Compensation Program in effect for 2025 is as described below, but was amended effective February 1, 2026, for 2026 compensation as described below.

The annual base retainer compensation was $750,000 for the Chairman of the Board, and $340,000 for all other non-employee directors, 40% of which was payable in cash and 60% of which was in the form of an equity stock compensation grant.

Cash Compensation

Cash compensation comprises 40% of the entire annual Board base retainer compensation, as follows:

•A $300,000 annual retainer paid quarterly to the Chairman of the Board (this retainer was terminated effective February 1, 2026. See “2026 Director Compensation Program Amendment” below).

•A $136,000 annual retainer paid quarterly to all other directors.

In addition to the base cash retainer, committee Chairs and the Lead Independent Director receive the following additional cash compensation:

•An additional $60,000 annual retainer paid quarterly to the Chair of the Audit Committee.

•An additional $50,000 annual retainer paid quarterly to each Chair of the Human Capital

Committee, the Nomination and Governance

Committee and the Sustainability Committee

•An additional $45,000 annual retainer paid quarterly to the Lead Independent Director (this retainer was increased to $50,000 effective February 1, 2026. See “2026 Director Compensation Program Amendment” below). .

Equity Compensation

In addition to the cash compensation set forth above, each non-management Director receives an annual equity stock compensation grant equal to 60% of the value of the entire annual Board base retainer compensation. In 2025, an equity grant valued at $450,000 was made to the Chairman of the Board, and an equity grant valued at $204,000 was made to each other director for their services in 2025.

The Nomination and Governance Committee selected restricted stock units as the sole form of equity for the 2025 grant. The restricted stock units are fully vested (non-forfeitable) after one-year from the date of grant, but a prorated portion will be paid out if a director’s service on the Board terminates before the one year anniversary of the grant unless the director is removed by the shareholders or is removed for cause, in which case the grant will be forfeited. Restricted stock units will be paid out as soon as practicable after the vesting in Linde plc ordinary shares on a one-for-one basis unless the payout has been deferred (See “Director Deferred Compensation” below).

The number of restricted stock units granted to deliver the $450,000 and $204,000 values, respectively, as of the March 7, 2025 grant date was based upon the average of the closing prices of the Company’s Ordinary Shares for the 60 trading days before and including February 14, 2025. Because the closing price of the Company’s Ordinary Shares on March 7, 2025 was higher than this 60-day average, the full grant date fair market value of the restricted stock units granted on March 7, 2025 and reported in the 2025 Director Compensation Table below was $479,552 for the Chairman of the Board, and $217,509 for each other director who received an equity grant.

Expenses

The Company pays or reimburses directors for travel, lodging and related expenses incurred in connection with attending board and committee meetings, the Annual General Meeting and other Company business-related

Linde plc 21

Corporate Governance and Board Matters

Director Compensation

events (including the expenses related to the attendance of spouses if they are specifically invited for appropriate business purposes) and may provide use of Company chartered aircraft. From time to time, the Company may reimburse a director’s expenses for his or her

participation in third party-supplied continuing education related to the director’s board or committee service.

Director Deferred Compensation

Pursuant to the Linde plc Non-Employee Director Deferral Program (“Program), non-employee directors may elect to defer to a later date, payment of some or all of the cash fees that may be earned in the upcoming year. A director chooses this deferred payment date when making a deferral election. Any deferred cash fees are converted into Linde deferred stock units ("DSUs") granted under the Linde plc 2021 Long Term Incentive Plan (“Equity Incentive Plan”), with each DSU representing the right to receive one Ordinary Share of Linde plc at the end of the deferral period. No other phantom investment options are available for deferred cash fees.

In addition, non-employee directors may elect to defer the payout of the annual director restricted stock unit (“RSU”) equity grant to a date later than the payout date that would otherwise occur after the RSU vests one year after the grant date. DSUs and RSUs are also credited with additional stock units whenever dividends are paid on the Company’s Ordinary Shares. Dividends are credited at the same rate as they are paid to all shareholders. Stock units provide directors the economic equivalent of owning the Company’s Ordinary Shares, except that the units may not be transferred or sold, and they do not provide any voting or other shareholder rights. DSUs and deferred RSUs are paid out solely in Company Ordinary Shares on the selected deferral payout dates.

2026 Director Compensation Program Amendment

In October 2025, the Nomination and Governance Committee reviewed and considered the Director Compensation Program in light of Board leadership changes.The Board amended the Director Compensation Program effective February 1, 2026 to: (1) terminate the separate compensation of the Chairman of the Board as CEO Sanjiv Lamba was appointed Chairman of the Board effective January 31, 2026, and (2) increase the annual cash retainer paid to the Lead Independent Director by $5,000 from $45,000 to $50,000. The additional cash compensation of the committee Chairs did not change.

22 Linde plc

Corporate Governance and Board Matters

Director Compensation

The table below shows the compensation of the Company’s non-management directors in 2025.

2025 Director Compensation Table

Name	Fees Earned or Paid in Cash ($)		Stock Awards ($)(1)		Option Awards ($)		Non-Equity Incentive Plan Compensation ($)		Change in Pension Value and Nonqualified Deferred Compensation Earnings		All Other Compensation ($)(2)		Total ($)
Stephen F. Angel (3)		300,000		479,552		—		—		—		40,000		$	819,552
Prof. DDr. Ann-Kristin Achleitner		184,500		217,509		—		—		—		—		$	402,009
Dr. Thomas Enders		184,500		217,509		—		—		—		—		$	402,009
				218,509
Hugh Grant		134,500		217,509		—		—		—		—		$	352,009
Joe Kaeser		184,500		217,509		—		—		—		—		$	402,009
Dr. Victoria E. Ossadnik		134,500		217,509		—		—		—		—		$	352,009
Paula Rosput Reynolds		134,500		217,509								—		$	352,009
Alberto Weisser		194,500		217,509		—		—		—		—		$	412,009
Robert L. Wood		177,000		217,509		—		—		—		—		$	394,509

(1)	Full grant date fair value of restricted stock units granted to each director on March 7, 2025, as determined under accounting standards related to share-based compensation.
(2)	Amounts in this column represent benefits provided to the directors that exceeded $10,000 per director. These amounts are the value of the following benefits provided to the directors by the Company: (a) $40,000 for Mr. Angel as 2025 matching contributions for his eligible personal charitable contributions pursuant to the Company’s charitable matching gift program that is available to Company employees and non-management directors on the same basis. The Company matches personal donations to eligible charitable institutions up to a $15,000 maximum per year per donor, with matches for certain charitable programs that may exceed the general $15,000 match.
(3)	Mr. Angel retired as Chairman of the Board effective January 31, 2026

Linde plc 23

Corporate Governance and Board Matters

Director Nominees

Director Nominees

Experience and Qualifications of All Nominees

Nine persons have been nominated for election to the Board to serve for a one-year term concluding on the later of (a) the 2027 annual general meeting of shareholders and (b) the election and qualification of his or her successor. The Nomination and Governance Committee has nominated each current director of the Board for reelection at the Annual General Meeting. The Nomination and Governance Committee believes that each director nominee has an established record of accomplishment in areas relevant to Linde’s business and objectives and possesses the characteristics identified in Linde’s Corporate Governance Guidelines as essential to a well-functioning and deliberative governing body, including integrity, independence and commitment.

Each of the director nominees listed below has experience as a senior executive of a public company or comparable business organization. Each nominee also is serving or has served as a director of one or more public companies and on a variety of board committees. As such, each has executive management and director oversight experience in most, if not all, of the following areas which are critical to the conduct of the Company’s business, including: strategy development and implementation, risk assessment and management, financial accounting and reporting, internal controls, corporate finance, capital project evaluation, the evaluation, compensation, motivation and retention of senior executive talent, public policies as they affect global industrial corporations, compliance, corporate governance, productivity management, safety management, project management, sustainable development and, in most cases, global operations. Many of the nominees also bring particular insights into specific end-markets and foreign markets that are important to the Company. These nominees collectively provide a range of perspectives, experiences and competencies well-suited to providing advice and counsel to management and to overseeing the Company’s business and operations. In addition to these qualifications that are shared by all of the nominees, more specific information about each of their individual experience and qualifications is included below.

The following pages include information about those persons currently serving on Linde’s Board of Directors who have been nominated for reelection to serve for a one-year term concluding on the later of (a) the 2027 annual general meeting of shareholders or (b) the election and qualification of his or her successor. The graph below shows the number of directors who have certain of the skills, qualifications and experience in key areas that are important for the Board’s oversight of the Company’s business.

Director Meeting Attendance

During 2025, the Board held five meetings. The nominees for reelection to the Board collectively attended 100% of all Board meetings and meetings of committees of which they were members.

24 Linde plc

Corporate Governance and Board Matters

Director Nominees

	Sanjiv Lamba
	Chairman of the Board and Chief Executive Officer of Linde plc
	Age Director Since Other Public Company Directorships	61 2022 Amphenol Corporation	Qualification Highlights •Industry •Linde End-Markets •Linde Foreign Markets •Operations •International Business •Technology •Risk Management •Public Company Board

Biography

Sanjiv Lamba was elected Chairman of the Board of Linde plc effective January 31, 2026, and was appointed Chief Executive Officer of Linde plc as of March 1, 2022. Prior to that, Mr. Lamba served as Chief Operating Officer for Linde plc from January 2021 to February 2022. Before his appointment as COO, Mr. Lamba was Executive Vice President, APAC since 2018.

Mr. Lamba started his career in 1989 with BOC in India in Finance, was appointed Director of Finance and subsequently Managing Director for the India business in 2001. He has worked in a number of geographies including India, UK, Singapore and Germany, where he served as member of the Executive Board of Linde AG.

Mr. Lamba served as Co-Chair on the Board of the Hydrogen Council and is a member of the Business Council. Mr. Lamba was appointed as a member of the Board of Directors of Amphenol Corporation in January 2026.

Experience and Qualifications

Mr. Lamba brings the senior executive experience and skills described above by virtue of serving as Linde’s Chairman and Chief Executive Officer, his prior service as the Chief Operating Officer, and his many years of leading Linde’s APAC segment as an Executive Vice President. He has substantial knowledge of the industrial gases and engineering industries. As the Chairman and CEO, Mr. Lamba facilitates Board discussions and keeps the Board apprised of significant developments in the Company’s business and industry.

Linde plc 25

Corporate Governance and Board Matters

Director Nominees

	Prof. DDr. Ann-Kristin Achleitner
	Professor at the Technical University Munich (TUM)
	Age Director Since Other Public Company Directorships	60 2018 Lazard Ltd. Deutsche Post AG (DHL)	Qualification Highlights •Linde Foreign Markets •International Business •Financial Expertise •Risk Management •Public Company Board

Biography

Prof. DDr. Ann-Kristin Achleitner has served as Scientific Co-Director of the Center for Entrepreneurial and Financial Studies since 2003 and has been Holder of Chair for Entrepreneurial Finance from 2001 to 2020 at Technical University Munich, Germany. She began her career with MS Management Service AG in St. Gallen, Switzerland in 1991. In 1992, she began as a university lecturer in Finance and External Auditing at the University of St. Gallen (HSG) in Switzerland. In 1994, she became a consultant at McKinsey & Company, Inc, in Frankfurt, Germany. In 1995, she was appointed Holder of the Endowed Chair for Banking and Finance and Chair of the Board of the Institute for Financial Management at the European Business School (International University Schloß Reichartshausen) in Oestrich-Winkel, Germany.

Prof. DDr. Achleitner is a member of the Board of Directors of Lazard Ltd., where she is a member of the Audit Committee and the Nominating & Governance Committee. She is also a member of the Supervisory Board of Deutsche Post AG (DHL) since 2024, where she serves on the Finance and Audit Committee. She is Founding Investor and Vice Chairwoman of planqc GmbH.

Prof. DDr. Achleitner was a member of the Advisory Board of Luxembourg Investment 261 S.à.r.L. (Techem GmbH), until October 2025, and a member of the Supervisory Board of Münchener Rückversicherungs-Gesellschaft AG (Munich Re) in Munich, Germany until April 2024. She was also a member of the Supervisory Board of Deutsche Börse AG in Frankfurt am Main, Germany, until May 2019 and a member of the Board of Directors of ENGIE SA in Paris, France, until May 2019. She was a member of the Supervisory Board of Linde AG from 2011-2019 where she was also member of the Audit Committee and the Nomination Committee. She also served as a member of the Supervisory Board of Metro AG in Düsseldorf, Germany, until February 2017, and as a member of the Board of Directors of Vontobel Holding AG and Vontobel Bank AG in Zurich, Switzerland until April 2013.

Experience and Qualifications

Prof. DDr. Achleitner is a Doctor of Business Administration and a Doctor of Law. Her educational background, along with her research and studies in the area of entrepreneurial finance, provides the Board with substantial financial expertise. She brings experience in international public company boards, audit, ethics, environment and sustainable development committees. Her years as a member of the Supervisory Board of Linde AG and service on the audit and nomination committees of Linde AG provides her with substantial experience and insight into the business segments of Linde and the financial performance of the Company.

26 Linde plc

Corporate Governance and Board Matters

Director Nominees

	Dr. Thomas Enders
	Former Chief Executive Officer of Airbus SE
	Age Director Since Other Public Company Directorships	67 2018 GE Aerospace	Qualification Highlights •Linde End-Markets •Linde Foreign Markets •Operations •International Business •Technology •Risk Management •Public Company Board

Biography

Dr. Thomas Enders served on the Executive Committee and the Board of Directors of EADS NV and its successor Airbus SE in various functions from 2000 to 2019. Between 2005 and 2019 he served as Chief Executive Officer of EADS/Airbus.

He joined the aerospace industry in 1991. Before that he worked in the German Bundestag, the German Ministry of Defense and in various foreign policy think tanks.

Dr. Enders has been a director of GE Aerospace, formerly named “General Electric Company,” since December 1, 2023. Dr. Enders served on the Board of Directors of Lilium N.V. from 2021-2025. Dr. Enders also served on the Supervisory Board of Lufthansa Group from May 2020 until May 2025. Dr. Enders was a member of the Supervisory Board of Linde AG from 2017 until 2019, where he was a member of the Standing Committee. He was a member of the Supervisory Board of Knorr-Bremse AG from June 2020 to May 2022. Since March 2022, Dr. Enders has been a member of the Board of Directors of Helsing, a European AI company. He is also President (non-executive) of the German Council on Foreign Relations (DGAP) in Berlin.

Experience and Qualifications

As the former Chief Executive Officer and member of the Executive Committee of Airbus SE, one of the largest aerospace companies in the world and a large international manufacturer, Dr. Enders contributes the senior executive experience and skills described above. In particular, his background includes extensive international, operational and manufacturing experience. As Airbus SE operates in many of the foreign markets in which the Company operates, Dr. Enders also brings his understanding of these large markets where the Company has a significant presence.

Linde plc 27

Corporate Governance and Board Matters

Director Nominees

	Hugh Grant
	Former Chief Executive Officer and Chairman of Monsanto Company
	Age Director Since Other Public Company Directorships	68 2023 Freeport-McMoRan, Inc.	Qualification Highlights •Linde Foreign Markets •Operations •International Business •Technology •Risk Management •Public Company Board

Biography

Hugh Grant retired as Chairman of the Board and Chief Executive Officer of Monsanto Company, a global provider of technology-based solutions and agricultural products that improve farm productivity and food quality, in June 2018 upon the closing of the merger of Monsanto Company and Bayer AG. He served as Chairman of the Board and Chief Executive Officer of Monsanto Company from 2003 until June 2018. Mr. Grant previously served as Executive Vice President and Chief Operating Officer of Monsanto Company at the time of an initial public offering in 2000 and remained in that position for the subsequent spin-off of the company in 2002.

Mr. Grant was a Director of PPG Industries, Inc. since September 2005, including as independent Lead Director since April 2014, until he retired from the PPG Board in December 2023. Mr. Grant is also a director of Freeport-McMoRan, Inc., since December 2021, serving on its Compensation Committee.

Mr Grant also serves on the boards of two Flagship Pioneering companies: Invaio Sciences, Inc. since February 2022 and CIBO Technologies, Inc. since June 2022. He is also a member of the American Academy of Arts & Sciences.

Experience and Qualifications

As a former Chief Executive Officer of Monsanto Company, Mr. Grant brings the senior executive experience and skills described above and has significant experience in the operations and management of a large, global business.

28 Linde plc

Corporate Governance and Board Matters

Director Nominees

	Joe Kaeser
	Former Chief Executive Officer of Siemens AG
	Age Director Since Other Public Company Directorships	68 2021 Daimler Truck Holding AG Siemens Energy AG	Qualification Highlights •Linde End-Markets •Linde Foreign Markets •Operations •International Business •Technology •Financial Expertise •Risk Management •Public Company Board

Biography

Joe Kaeser was the Chief Executive Officer of Siemens AG from August 2013 until February 2021. From May 2006 to August 2013, he was Chief Financial Officer of Siemens AG. Prior to this, Mr. Kaeser served as Chief Strategy Officer for Siemens AG from 2004 to 2006 and as the Chief Financial Officer for the mobile communications group from 2001 to 2004. Mr. Kaeser additionally held various positions within the Siemens group since he joined Siemens in 1980.

Mr. Kaeser is the Chairman of the Supervisory Board of Daimler Truck Holding AG, where he also chairs the Presidential and Remuneration Committee, the Mediation Committee, and the Nomination Committee. He is the Chairman of the Supervisory Board of Siemens Energy AG. Mr. Kaeser also served as a member of the Supervisory Board and of the Audit Committee of Daimler AG until October 1, 2021. He served as Vice Chairman of the Board of NXP Semiconductors N.V. and as a member of its Nominating and Governance Committee until he retired from the NXP Semiconductors Board on June 2, 2022.

Experience and Qualifications

As the former Chief Executive Officer of Siemens AG, a large global industrial manufacturing, technology and services company, Mr. Kaeser contributes the senior executive experience and skills described above. He has substantial operating experience and knowledge of numerous end markets and industries that are important to Linde’s business. Having also served as the Chief Financial Officer at Siemens, Mr. Kaeser also brings substantial financial expertise to Linde’s Board.

Linde plc 29

Corporate Governance and Board Matters

Director Nominees

	Dr. Victoria E. Ossadnik
	Management Board Member of E.ON SE
	Age Director Since Other Public Company Directorships	57 2018 E.ON SE Münchener Rückversicherungs- Gesellschaft AG	Qualification Highlights •Linde Foreign Markets •Operations •International Business •Technology •Risk Management •Public Company Board

Biography

Dr. Victoria Ossadnik became a Member of the Board of Management and Chief Operating Officer—Digital of E.ON SE in Essen, Germany effective April 1, 2021. Prior to that, she served as Chief Executive Officer of E.ON Energie Deutschland GmbH and E.ON Energie Deutschland Holding GmbH from April 2018 to April 2021. Prior to this, in 2011, she joined Microsoft Deutschland GmbH and was appointed as a member of the Board of Management from 2011 to 2016. She served as Vice President, Enterprise Services Delivery from 2016 to 2018.

Dr. Ossadnik began her career with SCANLAB GmbH, Germany, in 1996. From 1999 to 2003, she served as CEO of CSC Ploenzke AG, Germany, a joint venture with Dachser. In 2003, she joined Oracle Deutschland GmbH, serving as Head of Technology Consulting (Northern Europe) and, in 2007, was appointed a member of the Board of Management.

Dr. Ossadnik joined the Supervisory Board of Münchener Rückversicherungs Gesellschaft AG (Munich Re) in Munich, Germany in April 2024, and serves on the Audit Committee. She also served as a member of the Supervisory Board of Commerzbank AG until May 2021 where she served on the Committee for Digitalization and Technology. She was a member of the Supervisory Board of Linde AG from 2016 until 2019. From 2019 until 2020, she was also a member of Supervisory Board of innogy SE.

Experience and Qualifications

As a member of the Management Board of E.ON SE, one of the world’s largest investor-owned electric utility service providers and as the former Chief Executive Officer of E.ON Energie, the largest electricity supply company in Germany, Dr. Ossadnik brings the senior executive experience and skills described above. In addition, given her substantial senior management experience as the Chief Operating Officer – Digital at E.ON SE and previously at both Microsoft and Oracle in Germany, she contributes key insights and counsel as to Linde’s use of technology and further development of digitization in its business operations.

30 Linde plc

Corporate Governance and Board Matters

Director Nominees

	Paula Rosput Reynolds
	President and Chief Executive Officer of PreferWest, LLC
	Age Director Since Other Public Company Directorships	69 2024 GE Vernova National Grid plc	Qualification Highlights •Linde End-Markets •Linde Foreign Markets •Operations •International Business •Technology •Risk Management •Public Company Board

Biography

Paula Rosput Reynolds has been the president and CEO of PreferWest LLC, a business advisory firm and family office, since 2009. Ms. Reynolds started her career at Pacific Gas & Electric Corp in 1979 and spent over 40 years in the energy industry. She has held a number of executive positions during her career, including CEO of Duke Energy Power Services; Chair, president and CEO of AGL Resources; Chair and CEO of Safeco Corporation; and Vice-Chair and Chief Restructuring Officer of AIG. She was previously a nonexecutive director of TransCanada Corporation, CBRE Group, Inc, BAE Systems PLC, Anadarko Petroleum, Delta Air Lines and Coca Cola Enterprises, and Chair of the Seattle Cancer Care Alliance. Ms Reynolds also was the Senior Independent Director and Chair of the Remuneration Committee at BP plc until 2024.

Currently, Ms. Reynolds is the Chair of National Grid plc (appointed in 2021). She was a director of General Electric Company from 2018 through April 2024. Effective April 2, 2024, Ms. Reynolds became a director of GE Vernova, which was spun-off as a separate public company from General Electric Company, where she serves as the Chair of the Safety and Sustainability Committee.

Experience and Qualifications

Ms. Reynolds has had a long career leading global companies in the energy industry (a key Linde end market) and the financial sectors. Her experience with international and U.S. companies, including several restructuring processes and mergers, gives her insight into strategic and regulatory issues, which is an asset to the Board. Her wider business experience and understanding of the views of investors are also substantial contributions to the Board.

Linde plc 31

Corporate Governance and Board Matters

Director Nominees

	Alberto Weisser
	Former Chairman and Chief Executive Officer of Bunge Limited
	Age Director Since Other Public Company Directorships	70 2021 Bayer AG PepsiCo	Qualification Highlights •Linde End-Markets •Linde Foreign Markets •Operations •International Business •Financial Expertise •Risk Management •Public Company Board

Biography

Alberto Weisser served as Chairman and Chief Executive Officer of Bunge Limited, a global food, commodity and agribusiness company, from 1999 until June 2013, and as Executive Chairman until December 2013. Mr. Weisser previously served as Bunge’s Chief Financial Officer from 1993 to 1999. Prior to his tenure at Bunge, Mr. Weisser worked at BASF Group, a chemical company, in various finance-related positions. He also served as a Senior Advisor at Lazard Ltd. from 2015 until August 2018.

Mr. Weisser serves as a member of the Supervisory Board of Bayer AG and served on its Audit Committee from 2021 to 2024. He is also a member of the Board of Directors of PepsiCo, where he has been a member of the Audit Committee since 2011 and was Chairman of the Audit Committee from May 2016 to May 2025. He is also an advisor to Temasek International Pte. Ltd., a Singapore-based investment company.

Experience and Qualifications

As the former Chief Executive Officer of Bunge Limited, a global food, commodity and agribusiness company, Mr. Weisser contributes the senior executive experience and skills described above. He has substantial operating experience and knowledge of numerous end markets where Linde operates. Having also served as the Chief Financial Officer at Bunge, Mr. Weisser also brings substantial financial expertise to Linde’s Board and to the Audit Committee.

32 Linde plc

Corporate Governance and Board Matters

Director Nominees

	Robert L. Wood
	Lead Independent Director, Linde plc Former Chairman, President & Chief Executive Officer of Chemtura Corporation
	Age Director Since Other Public Company Directorships	72 2018 None	Qualification Highlights •Industry •Linde End-Markets •Operations •Risk Management •Public Company Board

Biography

Robert Wood is a Partner in the consulting firm The McChrystal Group, specializing in leadership development for business organizations. He was the Chairman, President & Chief Executive Officer of Chemtura Corporation, a specialty chemicals company, from 2004 until 2008. Prior to joining Chemtura, Mr. Wood served in various senior management positions at Dow Chemical Company, most recently as business group president for Thermosets and Dow Automotive from November 2000.

Mr. Wood is Linde’s Lead Independent Director. He was a director of MRC Global Inc., where he served as Chairman of the Board until November 4, 2024. He was a director of Univar Inc. until August 2023. Mr. Wood was a director of Praxair, Inc. from 2004 until 2018 and was the Lead Director and the Chairman of the Nomination and Governance Committee. He also was a director of Jarden Corporation, where he was a member of the Nominating and Policies Committee and Chairman of the Audit Committee.

Mr. Wood was Chairman of the American Plastics Council and the American Chemistry Council and was a member of the United States Olympic & Paralympic Committee.

Experience and Qualifications

As a former Chief Executive Officer of Chemtura Corporation, a global specialty chemicals company, and a former senior executive of Dow, a global chemicals company, Mr. Wood brings the senior executive experience and skills described above. He also has a deep understanding of the specific challenges and opportunities facing a global basic materials company. Mr. Wood’s knowledge of the chemicals industry, an important end-market for the Company, provides valuable insight to the Board and management.

Linde plc 33

Proposal 1: Appointment of Directors

Proposal 1: Appointment of Directors

Nine director nominees have been nominated for appointment to serve for a one-year term concluding on the later of (a) the 2027 annual general meeting of shareholders and (b) the election and qualification of their respective successors. The Nomination and Governance Committee has recommended to the Board, and the Board has approved and recommends, that Sanjiv Lamba, Prof. DDr. Ann-Kristin Achleitner, Dr. Thomas Enders, Hugh Grant, Joe Kaeser, Dr. Victoria E. Ossadnik, Paula Rosput Reynolds, Alberto Weisser and Robert L. Wood, each be appointed to serve for a one-year term concluding on the later of (a) the 2027 annual general meeting of shareholders and (b) the election and qualification of their respective successors. Each nominee has agreed to be named in this Proxy Statement and to serve if elected. Qualifications and biographical data for each of these nominees is presented above. If one or more of the nominees becomes unavailable for election or service as a director, the proxy holders will vote your shares for one or more substitutes designated by the Board of Directors, or the size of the Board of Directors will be reduced.

As required under Irish law, the resolution in respect of Proposal 1 is an ordinary resolution that requires the affirmative vote of a simple majority of the votes cast with respect to each director nominee (meaning that the number of shares voted “FOR” a nominee must exceed the number of shares voted “AGAINST” such nominee).

The text of the resolution in respect of Proposal 1 is as follows:

“By separate resolutions, to appoint the following nine directors: Sanjiv Lamba, Prof. DDr. Ann-Kristin Achleitner, Dr. Thomas Enders, Hugh Grant, Joe Kaeser, Dr. Victoria E. Ossadnik, Paula Rosput Reynolds, Alberto Weisser and Robert L. Wood,”

The Board recommends you vote “FOR” the re-appointment of each of the Board’s director nominees listed above.

34 Linde plc

Audit Matters

Oversight of Independent Auditors

Audit Matters

Oversight of Independent Auditors

The Audit Committee is directly responsible for the appointment, compensation (including approval of audit and non-audit fees), retention and oversight of the independent registered public accounting firm that audits Linde plc’s financial statements and its internal control over financial reporting. The Audit Committee has selected PricewaterhouseCoopers (“PwC”) as Linde plc’s independent auditor for 2026. PwC has served as Linde plc’s independent auditor since 2019. Representatives of PwC are expected to be present at the Annual General Meeting to be available to respond to appropriate questions and to make a statement if they desire.

During 2019, the Audit Committee conducted a comprehensive, competitive formal tender process to consider, and ultimately to recommend to the Board, the selection of an independent auditor for the Company. The Audit Committee considered and evaluated internationally recognized independent registered public accounting firms, including PwC, based upon a thorough set of criteria that the Audit Committee adopted. After conducting this process, the Audit Committee selected PwC as the independent auditor.

The Audit Committee will annually review the independence and performance of any potential independent auditor in deciding whether to select any given firm as the independent auditor. The Audit Committee considers, among other things, a firm’s:

•Recent performance on the Linde audit, if applicable;

•Capability and expertise in providing audit and related services to companies with the breadth and complexity of Linde’s worldwide operations;

•An analysis of the firm’s known legal risks and any significant legal or regulatory proceedings in which it is involved;

•External data on audit quality and performance, including recent Public Company Accounting Oversight Board (“PCAOB”) reports on the firm and its peer firms;

•The appropriateness of the firm’s proposed fees for audit and non-audit services;

•the firm’s independence (discussed below); and

•if applicable, the firm’s tenure as Linde’s independent auditor, including the benefits of having a tenured auditor and controls and processes that help ensure the firm’s independence.

Linde plc 35

Audit Matters

Auditor Independence

Auditor Independence

As noted in the Audit Committee Charter and in the Audit Committee Report presented below, the independent auditor reports directly to the Audit Committee and the Audit Committee is charged with evaluating its independence. The Audit Committee has adopted the policies and procedures discussed below that are designed to ensure that PwC is independent.

Based on this evaluation and representations from PwC, the Audit Committee believes that PwC is independent and that it is in the best interest of Linde and its shareholders to have PwC as the Company’s independent auditor for 2026.

Non-Audit Engagement Services Pre-Approval Policy

The Audit Committee has utilized PwC (along with other accounting firms) to provide non-audit services in 2025. Linde understands the need for PwC to maintain objectivity and independence as the auditor of the Company’s financial statements and its internal control over financial reporting. Accordingly, the Audit Committee has established a policy whereby all non-audit fees of the independent auditor must be approved in advance by the Audit Committee or its Chairman, and

has adopted a guideline that, absent special circumstances, the aggregate cost of non-audit engagements in a year should not exceed the audit fees for that year. The non-audit fees that are incurred are typically far less than this limit and, as noted below in the report on independent auditor fees, such non-audit fees were approximately 2% of total fees in 2025. All the Audit-Related Fees, Tax Fees and All Other Fees disclosed below were approved by the Audit Committee.

Audit Partner and Audit Firm Rotation

The Audit Committee’s policy and applicable regulations require that the lead audit engagement partner of the independent auditor must rotate off the Company’s account at least every five years. The Audit Committee believes that it is inappropriate to establish a fixed limit on the tenure of the independent auditor. Continuity and the resulting in-depth knowledge of the Company strengthens the audit. Moreover, the mandatory partner rotation policy expressed above, normal turnover of audit personnel, the Audit Committee’s policy regarding the hiring of auditor personnel as described below, and the

Audit Committee’s practices restricting non-audit engagements of the independent auditor as described above, all mitigate against any loss of objectivity that theoretically could arise from a long-term relationship. As provided in the Audit Committee’s Charter and as further described above, the Audit Committee continuously evaluates the independence and effectiveness of the independent auditor and its personnel, and the cost and quality of its audit services in order to ensure that the Audit Committee and the Company’s shareholders are receiving the best audit services available.

Hiring Policy – Auditor Employees

The Audit Committee has established a policy whereby no former employee of the independent auditor may be elected or appointed as an officer of the Company earlier than two years after termination of the engagement or employment.

36 Linde plc

Audit Matters

Fees Paid to the Independent Auditor

Fees Paid to the Independent Auditor

The Audit Committee authorizes and oversees the fees paid to PwC for audit and non-audit services. The aggregate fees billed by PwC in 2025 and 2024 for its services are set forth in the table below, followed by a description of the fees.

Types of Fees

	Audit		Audit - Related		Tax		All Other		Total
2025		21,610,000		280,000		70,000		10,000		21,970,000
2024		18,850,000		400,000		120,000		10,000		19,380,000

Audit Fees. These are fees paid for the audit of Linde plc’s annual U.S. GAAP financial statements, the reviews of the financial statements included in Linde plc’s reports on Form 10-Q, the opinion regarding Linde plc’s internal controls over financial reporting as required by §404 of the Sarbanes-Oxley Act of 2002, and services that are normally provided by the independent auditor in connection with statutory audits in foreign jurisdictions and regulatory filings or engagements for those fiscal years.

Audit-Related Fees. These are fees paid for assurance and related services rendered that are reasonably related to the performance of the audit or review of Linde plc’s financial statements other than the fees disclosed in the foregoing paragraph.

Tax Fees. These are fees paid for professional services rendered primarily for preparation of tax returns in non-U.S. jurisdictions and assistance with tax audits.

All Other Fees. These are fees paid for services rendered other than those described in the foregoing paragraphs. These services related primarily to online research tools and subscriptions.

Linde plc 37

Audit Matters

Audit Committee Report

Audit Committee Report

As set forth in the Audit Committee’s Charter, the management of the Company is responsible for: (1) the preparation, presentation and integrity of the Company’s financial statements; (2) the Company’s accounting and financial reporting principles; and (3) internal controls and procedures designed to ensure compliance with applicable laws, regulations, and standards, including internal control over financial reporting. The independent auditor is responsible for auditing the Company’s financial statements and expressing an opinion as to their conformity with generally accepted accounting principles and expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.

A principal role of the Audit Committee is to assist the Board of Directors in its oversight of the Company’s financial reporting process. In the performance of its oversight function, the Audit Committee has considered and discussed the audited financial statements with management and the independent auditor. The Audit Committee has also discussed with the independent auditor the matters that are required to be discussed in accordance with Public Company Accounting Oversight Board (PCAOB) standards relating to communications with audit committees.

The Audit Committee has discussed with the independent auditor its independence from the Company and its management. The Audit Committee has received the written disclosures and the letters from the independent auditor required by applicable requirements of the PCAOB. The Audit Committee has also received written communications from management with respect

to non-audit services provided to the Company by the independent auditor in calendar year 2025 and those planned for 2026. The Audit Committee has further considered whether the provision of such non-audit services is compatible with maintaining PricewaterhouseCoopers’ independence.

In its oversight role for these matters, the Audit Committee relies on the information and representations made by management and the independent auditor. Accordingly, the Audit Committee’s oversight does not provide an independent basis to certify that the audit of the Company’s financial statements has been carried out in accordance with generally accepted auditing standards, that the financial statements are presented in accordance with generally accepted accounting principles or that the Company’s independent auditor is, in fact, independent.

Based upon the review and discussions described in this report, and subject to the limitations on the role and responsibilities of the Audit Committee referred to above and in the Charter, the Audit Committee recommended to the Board that the audited financial statements be included in the Company’s Form 10-K and Annual Report for the year ended December 31, 2025 filed with the SEC.

The Audit Committee

Alberto Weisser, Chairman

Dr. Thomas Enders

Dr. Victoria E. Ossadnik

Paula Reynolds

38 Linde plc

Proposal 2: Non-Binding Ratification Appointment of Independent Auditor

and Binding Authorization of the Board to Determine its Remuneration

Proposal 2a: Non-Binding Ratification of the Appointment of the Independent Auditor

Proposal 2b: Authorization of the Board to Determine the Auditor’s Remuneration

Under Nasdaq and SEC rules, selection of the Company’s independent auditor is the direct responsibility of the Audit Committee. The Board has determined, however, to seek shareholder ratification of that selection as a good practice in order to provide shareholders an avenue to express their views on this important matter. If shareholders fail to ratify the selection, the Audit Committee may reconsider the appointment. Even if the current selection is ratified by shareholders, the Audit Committee reserves the right to appoint a different independent auditor at any time during the year if the Audit Committee determines that such change would be in the best interests of the Company and its shareholders.

Information concerning the independent auditor may be found under the caption “Audit Matters” above. The Audit Committee believes the selection of PwC as the Company’s independent auditor for 2026 is in the best interest of the Company and its shareholders.

In addition, Irish law provides that the remuneration of the Company’s statutory auditor may be

determined by shareholders at the AGM. At its February 2026 meeting, the Audit Committee approved PwC’s remuneration, subject to receiving the necessary shareholder approval at the 2026 AGM.

As required under Irish law, the resolutions in respect of Proposals 2a and 2b are ordinary resolutions that require the affirmative vote of a simple majority of the votes cast.

The text of the resolution in respect of Proposal 2a is as follows:

“To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers as independent auditor of Linde plc.”

The text of the resolution in respect of Proposal 2b is as follows:

“To authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to determine the remuneration of PricewaterhouseCoopers.”

The Board recommends that you vote “FOR” the ratification, on an advisory and non-binding basis, of the appointment of PricewaterhouseCoopers as independent auditor and “FOR” the authorization of the Board, acting through the Audit Committee, to determine the remuneration of PricewaterhouseCoopers.

Linde plc 39

Executive Compensation Matters

Compensation Discussion and Analysis

Executive Compensation Matters

Report of the Human Capital Committee

The Company’s Human Capital Committee (“HC Committee”) reviewed and discussed with management the “Compensation Discussion and Analysis” (“CD&A”) and recommended to the Board that it be included herein. The HC Committee has represented to management that, to the extent that the CD&A discloses the HC Committee’s deliberations and thinking in making executive compensation policies and decisions, it is accurate and materially complete.

The Human Capital Committee

Prof. DDr. Ann-Kristin Achleitner, Chairperson

Hugh Grant

Joe Kaeser

Robert L. Wood

Compensation Discussion and Analysis

This CD&A provides context for the policies and decisions underlying the 2025 compensation reported in the executive compensation tables included herein for the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), three other executive officers as of December 31, 2025 who had the highest total compensation for 2025, and an additional executive who was not an executive officer as of December 31, 2025 but otherwise would have been among the three executive officers with the highest total compensation for 2025, as set forth in the “Summary Compensation Table” (these executive officers are collectively referred to as the “Named Executive Officers” or the “NEOs”). The HC Committee is responsible for policies and decisions regarding compensation and benefits for the NEOs.

Executive Summary

Alignment of Executive Compensation with Company Performance

The HC Committee seeks to achieve its executive compensation objectives by aligning the design of the Company’s executive compensation programs with the Company’s business objectives, ensuring a balance between financial and non-financial goals.

2025 Company Performance Highlights

In 2025, Linde achieved strong financial results including return on capital (“ROC”) of 24.2% and operating cash flow of $10.4 billion. The Company grew adjusted operating profit by 4% year-over-year to $10.1 billion at a margin of 29.8% of sales, which was 30 basis points higher than prior year.(1) Linde delivered value to its shareholders by distributing $7.4 billion in the form of dividends and stock repurchases, while growing adjusted diluted earnings per share to $16.46, up 6% versus 2024. The Company ended 2025 with a project backlog of $10 billion and remains well-positioned to continue to deliver robust and sustainable performance into the future.

By weight, the three largest plan measures in NEOs’ target incentive pay are net income, after-tax ROC, and relative total shareholder return (“TSR”). The charts below illustrate performance in each.

1Adjusted income, operating profit and margin, earnings per share and after-tax ROC are non-GAAP measures. Please see “Reconciliation to Compensation and Non-GAAP Measures” on page 75 for a reconciliation to the applicable reported GAAP amount that is most comparable.

40 Linde plc

Executive Compensation Matters

Compensation Discussion and Analysis

2025 Compensation Highlights

Pay Mix at Target

The HC Committee emphasized long-term pay when setting each NEO’s total target compensation opportunity for 2025.

2025 Target Total Direct Compensation

Name	Title		Base Salary (1)		Target Annual VC (2)			Target Annual LTI Award (3)		Target Total Direct Compensation
Sanjiv Lamba		Chief Executive Officer	$	1,600,000		175	%	$	13,300,000	$	17,700,000
Matthew J. White		EVP, Chief Financial Officer	$	953,000		110	%	$	5,700,000	$	7,701,300
Guillermo Bichara		EVP, Chief Legal Officer	$	837,000		95	%	$	3,370,000	$	5,002,150
Sean F. Durbin		Chief Operating Officer	$	850,000		110	%	$	3,240,000	$	5,025,000
Benjamin Glazer		Senior Vice President, Americas	$	660,000		95	%	$	2,222,000	$	3,509,000
David P. Strauss		Former EVP, Chief Human Resources Officer	$	812,000		95	%	$	2,670,000	$	4,253,400

1.Represents annual base salary rate in effect as of December 31, 2025.

2.Represents annual variable compensation incentive target (as % of annual salary rate) in effect for 2025 plan year as of December 31, 2025.

3.Represents total target compensation value of LTI awards granted in 2025, which may differ from the grant values reported in the Summary Compensation Table (see the “2025 Equity Award Grants” section of the CD&A for more information).

Company Performance and Incentive Plan Payouts

Based on the Company’s 2025 performance, the annual variable compensation program’s Coporate Business Performance Factor was 116.0% of target. The Performance Share Units (“PSUs”) granted in 2023 achieved above-target payouts for the ROC component against the challenging goals that were established at the beginning of the three-year performance period. The PSU payout factors were 189% of target for the ROC component and 100% of target for the TSR component.

Linde plc 41

Executive Compensation Matters

Compensation Discussion and Analysis

Compensation Philosophy and Principles

The HC Committee’s compensation philosophy and guiding principles serve as the basis for the Company’s executive compensation program design.

Best Practices Supporting Executive Compensation Objectives

42 Linde plc

Executive Compensation Matters

Compensation Discussion and Analysis

Executive Compensation Design and Decisions

Elements of Executive Compensation

The following table describes each element of the Company’s executive compensation program.

Element	Form	Key Features
Base Salary	Cash	·  Competitive fixed pay to attract and retain executives. ·  Increases, if applicable, are typically made effective on April 1st of each year.
Annual Variable Compensation	Cash	·  Variable incentive to reward delivery of short-term financial and strategic objectives. ·  Payout determined based on performance against pre-established annual goals. ·  Performance weighting: ·  75% tied to financial performance (Sales, Net Income, Operating Cash Flow). ·  25% tied to non-financial performance (Core Values, Relative Performance & Strategic Positioning, and Greenhouse Gas Emissions). ·  Final payout reflects achievement against Variable Compensation goals, adjusted by an Individual Performance Factor (0.00 - 1.25), excluding the CEO.
Equity Awards	Performance Share Units (50%)	·  Performance measured equally on Return on Capital (ROC) and Relative Total Shareholder Return (TSR). ·  Vest on the third anniversary of the grant date, subject to achievement against pre-established goals.
	Stock Options (30%)	·  Vest in equal installments on the first, second and third anniversaries of the grant date. ·  Expire on the tenth anniversary of the grant date.
	Restricted Stock Units (20%)	·  Vest on the third anniversary of the grant date.

Aggregate Compensation

In establishing the 2025 compensation for each NEO, the HC Committee considered whether the value of each NEO’s aggregate compensation package was consistent with its objectives for Linde’s executive compensation program. It evaluated the following factors when determining compensation levels for NEOs:

•Market median data of international companies traded on the U.S. stock exchanges.

•Expected contribution to results, and exhibition of values, competencies and behaviors critical to the success of the Company.

•Internal equity: respective role, responsibilities and reporting relationships.

•Experience and time in similar roles.

•Retention objectives.

The HC Committee did not have a set formula for determining target compensation opportunity; however, it referred to the median benchmark data during its review. Additionally, the HC Committee acknowledged that its general practice will be to establish compensation levels toward the lower end of a competitive market range for an executive officer who is newer to their role. Conversely, a longer tenured executive officer with a history of strong performance will have target compensation levels set higher in the competitive range.

Linde plc 43

Executive Compensation Matters

Compensation Discussion and Analysis

2025 Decisions and Outcomes

Base Salary

The salary level for each NEO was established by the HC Committee after its consideration of multiple factors including positioning to market, CEO input (other than for himself), and advice from its compensation consultant (see the “Role of the Compensation Consultant” section for more information).

In January 2025, the HC Committee approved salary increases for the NEOs as follows, effective April 1, 2025.

	Lamba		White	Bichara	Durbin (1)	Glazer (2)	Strauss
Salary at December 31, 2024		$1,500,000	$920,000	$810,000	$750,000	$600,000	$785,000
Salary at December 31, 2025		$1,600,000	$953,000	$837,000	$850,000	$660,000	$812,000
Increase		6.7%	3.6%	3.3%	13.3%	10.0%	3.4%

(1)2025 salary was initially set to $778,000 effective April 1, 2025, and subsequently increased to $850,000 effective October 1, 2025, in connection with promotion to Chief Operating Officer.

(2)2025 salary was initially set to $620,000 effective April 1, 2025, and subsequently increased to $660,000 effective October 1, 2025, in connection with promotion to Senior Vice President, Americas.

Annual Performance-Based Variable Compensation

Overview

The HC Committee established an annual performance-based variable compensation program for the 2025 calendar year that focused executives on the key objectives that position Linde for sustained growth and the creation of shareholder value without compromising long-term business objectives or encouraging excessive risk-taking. The HC Committee decided not to make any changes to the general design of the program for 2025 compared to 2024.

Design

The HC Committee established the 2025 variable compensation target for each NEO (expressed as a percent of salary that would be earned for 100% achievement of plan goals). The targets for the NEOs ranged from 95% to 175% of salary.

	Lamba		White	Bichara	Durbin (1)	Glazer	Strauss
2025 Variable Compensation Target		175%	110%	95%	110%	95%	95%

(1)Represents 2025 annual variable compensation target in effect as of December 31, 2025. Overall 2025 annual variable compensation target amount based on 95% percent-of-salary target that was in effect for the period of January 1, 2025 through September 30, 2025, and 110% percent-of-salary target effective beginning October 1, 2025, in connection with promotion to Chief Operating Officer.

Financial Goals and Results

Awards under the annual variable compensation program are determined based on Company performance against challenging, pre-established financial goals. The financial component is weighted 75% of the total business performance factor and payouts related to this component can range from zero to 200% of target (for up to 150 percentage points).

To establish the goals related to the financial component of the program, the HC Committee considers many factors including the degree of control senior management may have over certain factors that affect financial performance. Goals are established with the expectation that executives will be rewarded with higher payouts if actual performance exceeds targets. Factors considered in setting the threshold, target, and maximum goals for each financial measure include:

•Management’s operating plan, including expected year-over-year challenges in performance.

•Macro-economic trends and outlooks in each of the countries in which the Company operates.

•Foreign exchange rate trends and outlook.

•Expected industrial gases peer performance and that of the broader S&P 500 and leading European companies.

44 Linde plc

Executive Compensation Matters

Compensation Discussion and Analysis

•Shifts in key customer markets.

•Expected contributions from contracts already awarded and decisions or actions already made or taken.

The chart below shows for each financial performance measure, the 2025 Corporate goals set by the HC Committee and the actual performance achieved. The overall Corporate Business Performance Factor for financial performance was 108.6% of target. The HC Committee did not apply discretion when determining the Business Performance Factor.

Financial Measure	Threshold		Target		Maximum		Actual		Weight			Achievement			Weighted Payout
Sales1 ($ millions)		31,202		33,406		35,271		33,424		20	%		101.0	%		20.2	%
Net Income1 ($ millions)		7,268		7,773		8,175		7,678		55	%		81.1	%		44.6	%
Oper. Cash Flow ($ millions)		9,067		9,913		10,493		10,350		25	%		175.3	%		43.8	%
									Total2							108.6	%

1For the annual variable compensation program, sales and net income are measured in accordance with GAAP, subject to certain adjustments that the HC Committee approves. Please see “Reconciliation to Compensation and Non-GAAP Measures” on page 75 for a reconciliation to the corresponding reported GAAP amounts.

2The payouts for Messrs. Lamba, White, Bichara, and Strauss are based on Linde plc Corporate results. However, the financial Business Performance Factors for Messrs. Durbin and Glazer are based on a blend of the business segment results for their respective business segments (weighted 75%) and the Linde plc Corporate results (weighted 25%). The overall weighted average Business Performance Factors for financial performance for Messrs. Durbin and Glazer were 110.2% and 110.7%, respectively.

Non-Financial Goals and Results

In alignment with the Company’s compensation philosophy, the design of the annual variable compensation program balances the need for management to deliver annual results with the desire to meet multi-year growth expectations. Selected key strategic and non-financial performance objectives are included to recognize these critical measures of the Company’s health and potential for future success.

The non-financial component is weighted 25% of the total Business Performance Factor and payouts related to this component can range from zero to 200% of target (for up to 50 percentage points). The three non-financial measures for 2025 were: Core Values (weighted 60%), Relative Performance and Strategic Positioning (weighted 20%), and Greenhouse Gas Emissions (weighted 20%).

The charts that follow show for each non-financial performance measure, the 2025 Corporate goals set by the HC Committee and the achievements against those goals. The overall Corporate non-financial Business Performance Factor was 138.2% of target.

The HC Committee evaluated performance under the measures of Core Values, and Relative Performance and Strategic Positioning, based on the accomplishments described previously, and set Business Performance Factors as follows:

Linde plc 45

Executive Compensation Matters

Compensation Discussion and Analysis

Performance Measure	Threshold			Target			Maximum			Achievement
Core Values		0	%		100	%		200	%		135	%
Relative Performance & Strategic Positioning		0	%		100	%		200	%		135	%

Absolute Greenhouse Gas Emissions were 35.8 MM MT, resulting in a Business Performance Factor of 151.0%:

Performance Measure	Threshold		Target	Maximum	Actual	Achievement
Greenhouse Gas ("GHG") Emissions (MM MT)		41.5	37.4	34.2	35.8	151.0%

The overall Corporate non-financial Business Performance Factor was 138.2% based on achievement for each measure:

Performance Measure	Weight	Achievement	Weighted Payout
Core Values	60%	135.0%	81.0%
Relative Performance & Strategic Positioning	20%	135.0%	27.0%
GHG Emissions	20%	151.0%	30.2%
Overall Corporate Non-Financial Performance Factor			138.2%

Individual Performance Factor

To reinforce a culture where pay is directly linked to performance and to recognize the contributions of individuals to overall Company results, an individual performance component is included in the annual variable compensation design. Excluding the CEO, the HC Committee may make a positive, negative, or no adjustment (via a multiplier that can range from 0 to 1.25) to each NEO’s variable compensation award based on its evaluation of their individual performance. For the CEO, the HC Committee may make a negative or no adjustment to his incentive award based on his performance.

In evaluating if an individual performance adjustment was appropriate, the HC Committee will consider various qualitative factors, such as the NEO’s:

•Performance in their principal areas of responsibility.

•Degree of success in leading the Company to meet its strategic objectives.

•Driving the key values (including sustainable development; safety, health and environment; inclusion; community engagement; and integrity and compliance) and competencies that are important to the Company’s success.

For the variable compensation awards related to the 2025 plan year, adjustments were made to the payouts of each NEO (other than the CEO) based upon individual performance in 2025. When considering the individual performance, the HC Committee considered each NEO’s individual achievements in the qualitative categories above. None of the adjustments made were material to annual performance-based variable compensation payments.

2025 Payout Summary

Set forth below are tables with the calculations of the overall 2025 Corporate Business Performance Factor and the CEO’s 2025 variable compensation payout determined in accordance with the results described previously.

Component		Weight	Achievement	Weighted Payout
Financial		75%	108.6%	81.45%
Non-Financial		25%	138.2%	34.55%
	Overall Performance Factor			116.0%

	Base Salary		Variable Compensation Target	2025 Overall Performance Factor	2025 Actual Payout
Lamba		$1,575,000	175%	116.0%	$3,197,250

2026 Design

In order to promote year-over-year consistency, the HC Committee has determined to maintain the same design structure of the Company’s annual performance-based variable compensation program with the applicable performance measures updated for 2026.

46 Linde plc

Executive Compensation Matters

Compensation Discussion and Analysis

Equity Awards

Overview

Equity awards are the largest portion of each NEO’s target compensation to ensure a strong alignment of NEOs’ and shareholders’ long-term interests. Annual grants of equity awards are made to incent and reward sustained performance.

Equity awards are granted as a mix of stock options, performance share units (PSUs), and restricted stock units (RSUs). The mix and type of equity awards granted to the CEO and other NEOs is the same as those granted to all eligible executives of the Company. Fully aligning the leadership team, from mid-management to officers, helps sustain the Company’s pay for performance culture by linking all participants to the same goals and performance results.

Grant Practices

The HC Committee generally meets in January and February each year to consider prior year performance under Linde’s incentive programs. At the February meeting, the HC Committee approves annual equity awards with a grant date of on March 7th of each year (or the next business day if March 7th is a non-business day). The HC Committee may also grant equity awards at other points during the year in connection with recruiting, promotions, or other circumstances.

Linde’s equity grant practices reflect the HC Committee’s intent that grants of equity awards generally be made when the Company is not in possession of material nonpublic information.

Linde typically publicly releases fourth quarter and full year financial results in a press release and SEC Form 8-K filing in late January or early February of each year, before the February HC Committee meeting at which the equity grants are approved. Linde also files its annual report on Form 10-K by the end of February each year, after the HC Committee meeting at which equity grants are approved, but before the typical March 7th equity grant date.

As such, the HC Committee does not time the disclosure of any material nonpublic information for the purpose of affecting the value of equity grants, including those granted in 2025. No stock options were granted to any NEO in 2025 during the period beginning four business days before the filing of Linde’s Form 10-Q, Form 10-K, or Form 8-K that discloses material nonpublic information, and ending one business day after the filing of any such report.

2025 Grant Values

The HC Committee established the target dollar value of 2025 equity awards for each NEO. The HC Committee examined the relative responsibilities of the NEOs and each NEO’s position to market with consideration of how long they had been in their current roles. Particular emphasis was placed on the importance of providing NEOs an incentive and appropriate reward for taking high quality actions to support sustainable long-term growth.

In order to facilitate the HC Committee’s approval at its February meeting of the total number of shares to be granted, and to avoid an outsized impact to grant quantities from short-term fluctuations in the stock price, each award type is valued for compensation purposes based on a 60-day trading average through the middle of February of the grant year. These compensation values are used to derive the number of options and units to be granted to each NEO from the dollar-value LTI targets that are approved by the HC Committee at its January meeting.

Because of stock price fluctuations between the compensation valuation period and the March grant date when the accounting values are measured, the accounting values of the LTI awards in the Summary Compensation Table on page 52 may differ from the LTI grant amounts approved by the HC Committee in any given year.

The table below shows the LTI grant amounts that were approved for each NEO by the HC Committee in 2024 and 2025.

	Lamba		White	Bichara	Durbin	Glazer	Strauss
2024 LTI Grant		$12,450,000	$5,100,000	$3,050,000	$2,880,000	$1,900,000	$2,400,000
2025 LTI Grant		$13,300,000	$5,700,000	$3,370,000	$3,240,000	$2,222,000	$2,670,000
Increase		6.8%	11.8%	10.5%	12.5%	16.9%	11.3%

Linde plc 47

Executive Compensation Matters

Compensation Discussion and Analysis

Performance Share Unit Goals and Results

As previously described, the PSU component of the Company’s equity awards program includes two equally weighted metrics: ROC and TSR.

The PSU awards granted in March 2025 include ROC and TSR goals covering calendar years 2025 through 2027. ROC goals are set by the HC Committee based on a number of factors, including prior-year ROC results, industry ROC averages, capital expenditure projections, and the Company’s weighted average cost of capital. In order to align with the Company’s global shareholder base, TSR performance is measured against a blended group of companies that is comprised of those that are listed on the S&P 500, excluding the Financial sector (weighted 67%), plus those that are designated as Eurofirst 300 (weighted 33%) at the start of the three-year performance period.

2025-27 PSU Goals		Threshold	Target	Maximum
Average	Goal	24.5%	25.3%	26.5%
Annual ROC	Payout	50%	100%	200%
Relative	Goal	25th %ile	50th %ile	75th %ile
TSR Rank	Payout	25%	100%	200%

•Payout is interpolated for results between threshold and maximum.

•ROC is the Company’s after-tax return on capital as reported in its quarterly and annual Consolidated Financial Statements, adjusted to eliminate the after-tax effect of any acquisition occurring during the performance period that was not known at the time the goals were set.

In March 2026, the grants of the ROC- and TSR-measured PSUs that met the pre-established performance criteria at the end of 2025, vested and were settled in Company shares.

The Company achieved an industry-leading average annual ROC over the three-year performance period of 25.2%, which exceeded the pre-established goal for target performance of 24.4%. The HC Committee certified the vesting at 189% of the target number of ROC PSUs granted.

The Company’s TSR over the three-year performance period ended at the 50th percentile of the pre-established peer group comprised of companies that were listed on the S&P 500, excluding the Financial sector, plus companies that were designated as Eurofirst 300 at January 1, 2023. This corresponded to achievement at target, and the HC Committee certified the vesting at 100% of the target number of TSR PSUs granted.

2023-25 PSU Payouts	Threshold Goal		Target Goal	Maximum Goal	Actual Result	Payout
Average Annual ROC*		23.0%	24.4%	25.3%	25.2%	189%
Relative TSR Rank		25th %ile	50th %ile	75th %ile	50th %ile	100%

* Adjusted after-tax return on capital (“ROC”) is a non-GAAP measure. Please see “Reconciliation to Compensation and Non-GAAP Measures” on page 75 for a reconciliation to the reported GAAP amounts that are most comparable.

2026 Design

In order to promote year-over-year consistency, the HC Committee maintained the same equity awards program design but with the applicable performance targets updated for 2026 awards.

48 Linde plc

Executive Compensation Matters

Compensation Discussion and Analysis

How Compensation Decisions Are Made

Shareholder Engagement

The Company maintains a robust outreach program whereby management regularly discusses plan design and other relevant matters with shareholders. At the July 2025 Annual General Meeting of Shareholders, approximately 94.1% of the votes cast were in favor of the Company’s Advisory Vote on NEO Compensation. When making compensation decisions, the HC Committee considered these results, as well as shareholder feedback received in outreach sessions.

Role of the Human Capital Committee

The HC Committee reviews and approves the corporate goals and objectives relevant to the CEO’s compensation, evaluates the CEO’s performance relative to those goals, and determines and approves the CEO’s compensation. The HC Committee also reviews the performance of the other NEOs against the goals and objectives relevant to their compensation, and reviews and approves the compensation of the other NEOs.

Role of the Compensation Consultant

The HC Committee engages a third-party compensation consultant to assist in analysis to inform and support the HC Committee’s executive compensation decisions. The HC Committee engaged Pearl Meyer LLC as its compensation consultant through April 2025 and selected Willis Towers Watson (“WTW”) as its compensation consultant beginning thereafter.

Before engaging WTW, and as part of its standard practice to conduct an annual review, the HC Committee assessed the independence of the compensation consultant. After considering the six independence factors specified in the Nasdaq listing standards, the HC Committee determined that WTW met the criteria for independence.

The scope of WTW’s engagement includes:

•Review of compensation programs, preparation and presentation to the HC Committee of reports on executive compensation trends and other various materials.

•Review of the peer group analysis and compensation benchmarking studies prepared by management and review of other independent compensation data.

•Advice on the determination of NEO’s compensation, the consultant’s view of the CEO’s recommendations for other NEO compensation, as well as input on the CEO’s compensation.

•Review and advice on compensation program design proposals presented by management to the HC Committee.

Compensation Peer Group

The HC Committee established a Compensation Peer Group to be used to assess competitive market compensation ranges for its top officers. Elements considered by the HC Committee when choosing companies for peers included market capitalization, revenue, net income, sector, global operations, location of headquarters, and stock markets where publicly traded. The HC Committee reviews the peer group on an annual basis, though will only make changes when appropriate as it values year-over-year consistency. The table below lists the companies comprising the Compensation Peer Group that was used for making pay decisions for calendar year 2025.

Risk Considerations

The HC Committee reviews the design of the Company’s incentive compensation plans on an annual basis to confirm that the incentive programs do not encourage excessive risk taking. During the HC Committee’s review in February 2025, sufficient controls to incentive plan design were identified, including payout caps, a blend of multiple financial and non-financial factors, and the significant weight given to rewarding long-term performance through equity awards.

Based on this review, management and the HC Committee do not believe that the Company’s incentive compensation plans create risks that are reasonably likely to have a material adverse effect on the Company.

Linde plc 49

Executive Compensation Matters

Compensation Discussion and Analysis

Additional Compensation Information

Health, Welfare and Retirement Benefits

Competitive benefits are provided to attract executive talent, promote employee health and well-being, provide opportunity for retirement income accumulation, encourage long-term service, and where allowed, to include opportunities to invest in Company stock.

Generally, the Company makes available to NEOs benefits that are similar to those provided to other employees based upon the location of their employer and provides perquisites and personal benefits consistent with local market practices.

U.S. Tax-Qualified Pension Plan

•The Company maintains a tax-qualified pension plan for eligible U.S. employees, including NEOs.

U.S. Supplemental Retirement Income Plan

•The plan is maintained for the primary purpose of providing retirement benefits that would otherwise be paid to eligible employees under the U.S. tax-qualified pension plan but for certain federal tax limitations.

•Incremental benefits paid are calculated in the same manner as the underlying U.S. tax-qualified pension plan.

•Only base salary and annual variable compensation awards are considered in pension calculations.

Pension Commitments for Mr. Lamba

•Mr. Lamba has been a U.S. employee eligible for the Company’s U.S. benefits programs since January 1, 2022. He retains pension entitlements that accrued in connection with his earlier employment with a Company affiliate under an individual pension agreement. Additional information is included under the heading “Additional Information Regarding 2025 Pension Benefits Table.”

U.S. 401(k) Plan

•Eligible U.S. employees, including NEOs, may make voluntary contributions to the plan that are invested in various available investment options, including Company stock, as directed by the NEO.

•The Company matches employees’ contributions based on a formula specified in the plan.

U.S. Deferred Compensation

•U.S. employees eligible to participate in the Variable Compensation Plan, including NEOs, may participate in the plan.

•Employee contributions to the plan are voluntary and represent compensation already earned by the participants.

•The Company also makes a contribution to the plan equal to the matching contributions that would have been made to the employee’s 401(k) plan account but for the application of certain federal tax limits.

•No above-market earnings are payable.

Other Plans

•Medical and dental coverage, disability, life insurance, relocation and vacation programs are provided.

Other Compensation Policies and Considerations

Perquisites and Personal Benefits

In addition to the compensation elements described previously, the Company offers certain perquisites and personal benefits to the NEOs on a limited basis. For 2025, the HC Committee reviewed and approved items that could be construed as perquisites or personal benefits for each NEO to ensure they are consistent with local country market practice or otherwise are provided for limited and specifically defined business purposes.

50 Linde plc

Executive Compensation Matters

Compensation Discussion and Analysis

International Assignment Benefits

The Company provides certain benefits to employees who relocate to another country at the Company’s request, as part of its global mobility program. These benefits include relocation expenses, host country housing and transportation, allowances for goods and services, tax preparation services, and income tax equalization. The goal of these benefits is to ensure that employees are not financially advantaged or disadvantaged as a result of their relocation or international assignment, including related taxes.

Generally, while on an international assignment, NEOs continue to receive pay and health, welfare and retirement benefits from their home countries.

Severance Benefits

The Company provides severance benefits to eligible employees, including NEOs, consistent with the terms of its severance programs, applicable local law, and local practices.

Additional information about the Company’s severance arrangements applicable to the NEOs is included in the section entitled “Severance and Other Change-In-Control Benefits.”

Stock Ownership, Retention Requirements, Hedging, and Pledging

In order to align executives’ interests with shareholder interests, the HC Committee has established a stock ownership policy for NEOs (see disclosure on details of this policy in the “Executive Stock Ownership and Shareholding Policy” section). NEOs may comply with this policy by acquiring Company stock or stock-equivalent units through LTI grants, as well as, if eligible, through the Company’s Compensation Deferral Program, 401(k) Plan, Dividend Reinvestment and Stock Purchase Plan, and through other personal investments.

Under the Company’s Stock Ownership Policy, unless the stock ownership level is met, an executive officer may not sell any of their holdings of Company stock and must hold all shares acquired upon vesting of PSUs or RSUs and option exercises, in each case net of shares withheld to pay applicable taxes and/or the option exercise price.

An executive officer may not engage in hedging transactions related to Company stock that would have the effect of reducing or eliminating the economic risk of holding Company stock. In addition, no executive officer may pledge or otherwise encumber any of their Company stock.

Recapture Clawback Policy

In the event that the Company is required to prepare an accounting restatement due to material noncompliance with any financial requirement under securities laws, the HC Committee requires the reimbursement of amounts of incentive compensation received by all Section 16 officers in excess of the amounts that otherwise would have been received had they been determined based on the restated results, computed without regard to any taxes paid. The recovery of such excess incentive compensation is made for the three completed fiscal years immediately preceding the date that the Company is required to prepare the restatement. For purposes of the policy, incentive compensation includes any compensation that is granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure, and includes the Company’s annual variable compensation and PSU awards based on the current design of such programs.

In addition, the HC Committee has the authority to cancel LTI awards and/or recover any gains realized by an employee in connection with an LTI award when, irrespective of whether or not the Company is required to prepare an accounting restatement, the HC Committee determines that the employee engaged in certain prohibited activities, including those that constitute a conflict of interest with the Company, are prejudicial to the Company’s interests, violate the employee’s continuing noncompete and/or confidentiality obligations to the Company, or violate Company policy (including its Code of Business Integrity).

Tax and Accounting

The accounting treatment of the compensation program was reviewed by the HC Committee but did not impact the selection and design of the annual variable compensation program or equity compensation for 2025, although all of the equity awards to the NEOs were made in such a manner as to not require liability accounting treatment.

Linde plc 51

Executive Compensation Matters

Executive Compensation Tables

Executive Compensation Tables

The tables below present compensation information for the Company’s NEOs and include footnotes and other narrative explanations important for understanding the compensation information in each table. The Summary Compensation Table summarizes key components of NEO compensation for 2023, 2024 and 2025.

The tables following the Summary Compensation Table provide more detailed information about the various types of NEO compensation for 2025, some of which are included in the Summary Compensation Table. The final table provides information regarding compensation that NEOs would receive if their employment with the Company terminates under various circumstances or in connection with a change-in-control.

Summary Compensation Table

Name and Principal Position	Year		Salary ($)(1)		Stock Awards ($)(2)		Option Awards ($)(2)		Non-equity Incentive Plan Compensation ($)(3)		Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)(4)		All Other Compensation ($)(5)		Total ($)
Sanjiv Lamba,		2025		1,575,000		11,680,804		4,938,908		3,197,250		198,000		187,908		21,777,870
Chief Executive Officer		2024		1,475,000		11,473,602		4,677,524		2,698,070		221,748		150,144		20,696,088
		2023		1,375,000		9,409,791		3,880,751		3,480,263		868,883		185,567		19,200,255
Matthew J. White,		2025		944,750		5,007,108		2,116,738		1,386,326		173,000		42,238		9,670,160
Executive Vice President &		2024		910,000		4,702,961		1,916,399		1,292,491		161,000		40,250		9,023,101
Chief Financial Officer		2023		870,000		3,849,416		1,587,789		1,791,006		156,000		38,500		8,292,712
Guillermo Bichara		2025		830,250		2,960,304		1,251,523		1,006,429		126,000		57,428		6,231,934
Executive Vice President &		2024		798,750		2,812,145		1,146,010		914,460		116,000		68,788		5,856,153
Chief Legal Officer		2023		758,750		2,253,317		927,815		1,271,585		115,000		67,028		5,393,494
Sean F. Durbin		2025		789,000		2,845,953		1,203,235		1,058,167		112,000		67,059		6,075,414
Chief Operating Officer		2024		737,500		2,658,769		1,082,374		859,247		105,000		48,575		5,491,465
		2023		693,750		2,140,162		882,198		1,167,416		101,000		2,400,307		7,384,833
Benjamin W. Glazer (6)		2025		625,000		1,952,919		825,214		769,998		90,000		100,498		4,363,629
Senior Vice President,
Americas
David P. Strauss		2025		722,256		2,345,152		991,517		875,310		290,000		26,979		5,251,214
Former Executive Vice President &		2024		773,750		2,213,228		902,166		933,294		29,000		28,814		4,880,252
Chief Human Resources Officer (7)

(1)Amounts reported are actual salaries paid for the calendar year and include adjustments to base salary rates, if applicable.

(2)These amounts were not paid in the respective year but rather are the full grant date fair value of equity awards made for each year as determined under accounting standards related to share-based compensation. The Stock Awards amounts are the values for the PSU grants made in each year valued at the target number of shares granted and the values of RSU grants made to each NEO in each year. The Option Awards amounts are the values for options granted in each year. The assumptions used in computing the Option Awards and Stock Awards amounts are included in Note 15 to the Company’s 2025 financial statements in the 2025 Form 10-K and Annual Report. The amounts shown in the Stock Awards and Option Awards columns are subject to vesting conditions that may or may not result in actual payouts in future years. In addition, a stock option has value only if the Company’s stock price increases above the option exercise price (an “in-the-money” option). If a NEO exercises an in-the-money option, the NEO would then realize an actual gain. Any gain realized for options exercised in 2025 and the value realized in connection with PSUs and RSUs that vested in 2025, are reported in the “2025 Option Exercises and Stock Vested” table.

(3)Each NEO was paid a performance-based variable compensation payment in 2026 based upon the Company’s 2025 performance, in 2025 based upon the Company’s 2024 performance, and in 2024 based upon the Company’s 2023 performance. These amounts are reported as “Non-equity Incentive Plan Compensation.” See the detailed description of the 2025 awards and the Company’s Variable Compensation Plan in the CD&A under the section “Annual Performance-Based Variable Compensation.”

(4)Amounts in this column are the annual increase in actuarial present value of retirement benefits payable under the Company’s Pension Program. The amounts reported for Mr. Lamba include retirement benefits payable under his pension agreement that was in effect prior to him becoming a U.S. employee. These amounts were not actually paid to any NEO. The total pension present value accrued for each NEO through 2025 is disclosed in the 2025 Pension Benefits table. See the detailed description of the pension benefits under “Additional Information Regarding 2025 Pension Benefits Table” for further information. No amounts accumulated under the Company’s Compensation Deferral Program earn above market or “preferential” interest or other earnings; therefore, no earnings are included in this column.

52 Linde plc

Executive Compensation Matters

Executive Compensation Tables

(5)This column includes any perquisites or personal benefits that exceeded $10,000 for any NEO during 2025, valued at incremental costs. NEOs were not reimbursed for any taxes due based on the imputed value of Company-provided perquisites or personal benefits not generally available to all employees. Such perquisites or personal benefits were:

Name	Matching   Contribution		Charitable   Giving		Personal   Use of   Company   Aircraft		Financial  Planning		Other
Sanjiv Lamba		78,750		30,000		62,743		14,915		1,500
Matthew J. White		41,238		—		—		—		1,000
Guillermo Bichara		41,513		1,000		—		14,915		—
Sean F. Durbin		39,127		13,125		—		5,762		9,045
Benjamin W. Glazer		30,708		53,875		—		14,915		1,000
David P. Strauss		25,979		—		—		—		1,000

Matching Contribution includes Company contributions to the Company’s U.S. 401(k) Plan and Compensation Deferral Program described under the “2025 Nonqualified Deferred Compensation” table.

Charitable Giving includes payments made by the Company to qualified charitable organizations under the Company’s U.S. Matching Gift Program. In general, the program, which is available to all U.S. employees, provides a matching contribution on gifts made by an employee to one or more tax exempt 501(c)(3) charitable organizations located in the U.S. and qualified charitable organizations outside the U.S., subject to certain annual limits.

For reasons of security and time management, the Board requires the CEO to use the Company’s corporate aircraft for personal use as well as business travel. The aircraft is available for the Company’s use through a time-share arrangement with a fixed time-share charge for the right to use the aircraft and a per-trip charge. The Company calculates the incremental aircraft costs for the CEO’s personal use as the full amount of those per-trip charges attributable to his personal use. The fixed time-share charge is not included as an incremental cost, as the Company must pay this amount even if the CEO does not use the aircraft for personal travel.

Other perquisites include Health Savings Account contributions and, for Mr. Durbin, relocation benefits provided in connection with his promotion to Chief Operating Officer.

(6)Because Mr. Glazer was not an NEO in 2023 or 2024, only 2025 compensation is provided for him.

(7)Because Mr. Strauss was not an NEO in 2023, only 2024 and 2025 compensation is provided for him. Mr. Strauss ceased executive officer responsibilities in September 2025 when he announced that he would retire in March 2026 and serve as Advisor to the CEO in the interim. After 35 years of service, Mr. Strauss retired from employment with the Company effective as of March 31, 2026.

Linde plc 53

Executive Compensation Matters

Executive Compensation Tables

2025 Grants of Plan-Based Awards

Below is information regarding the 2025 Non-Equity Incentive Plan Compensation, Stock Awards and the Option Awards reported in the Summary Compensation Table. The 2025 option grants, PSU and RSU awards reported in the table below were made under the 2021 Linde plc Long Term Incentive Plan. The awards granted to NEOs were made on substantially the same terms as the 2025 grants that were made to all other eligible employees.

		Grant		HC Committee Approval	Estimated Possible Payouts Under Non-Equity Incentive Plan Awards						Estimated Future Payouts Under Equity Incentive Plan Awards							All Other Stock Awards: Number of Shares of Stock or	All Other Option Awards: Number of Securities Underlying		Exercise or Base Price of Option		Grant Date Fair Value of Stock and Option
Name	Date (1)		Date (1)		Threshold ($)		Target ($)		Maximum ($)		Threshold (#)		Target (#)		Maximum (#)		Units (#)		Options (#)		Awards ($/Sh)		Awards ($)(6)
Sanjiv Lamba
Variable Cash (2)						—		2,756,250		5,512,500
Stock Options (3)		3/7/2025		2/25/2025																44,696		468.77		4,938,908
RSUs (4)		3/7/2025		2/25/2025														6,364						2,881,301
ROC PSUs (5)		3/7/2025		2/25/2025								—		7,955		15,910								3,601,626
TSR PSUs (5)		3/7/2025		2/25/2025								—		7,955		15,910								5,197,877
Matthew J. White
Variable Cash (2)						—		1,039,225		2,598,063
Stock Options (3)		3/7/2025		2/25/2025																19,156		468.77		2,116,738
RSUs (4)		3/7/2025		2/25/2025														2,728						1,235,102
ROC PSUs (5)		3/7/2025		2/25/2025								—		3,410		6,820								1,543,878
TSR PSUs (5)		3/7/2025		2/25/2025								—		3,410		6,820								2,228,128
Guillermo Bichara
Variable Cash (2)						—		788,738		1,971,844
Stock Options (3)		3/7/2025		2/25/2025																11,326		468.77		1,251,523
RSUs (4)		3/7/2025		2/25/2025														1,613						730,286
ROC PSUs (5)		3/7/2025		2/25/2025								—		2,016		4,032								912,744
TSR PSUs (5)		3/7/2025		2/25/2025								—		2,016		4,032								1,317,275
Sean F. Durbin
Variable Cash (2)						—		781,425		1,953,563
Stock Options (3)		3/7/2025		2/25/2025																10,889		468.77		1,203,235
RSUs (4)		3/7/2025		2/25/2025														1,551						702,215
ROC PSUs (5)		3/7/2025		2/25/2025								—		1,938		3,876								877,430
TSR PSUs (5)		3/7/2025		2/25/2025								—		1,938		3,876								1,266,309
Benjamin W. Glazer
Variable Cash (2)						—		593,750		1,484,375
Stock Options (3)		3/7/2025		2/25/2025																7,468		468.77		825,214
RSUs (4)		3/7/2025		2/25/2025														1,064						481,726
ROC PSUs (5)		3/7/2025		2/25/2025								—		1,330		2,660								602,158
TSR PSUs (5)		3/7/2025		2/25/2025								—		1,330		2,660								869,035
David P. Strauss
Variable Cash (2)						—		686,143		1,715,358
Stock Options (3)		3/7/2025		2/25/2025																8,973		468.77		991,517
RSUs (4)		3/7/2025		2/25/2025														1,278						578,615
ROC PSUs (5)		3/7/2025		2/25/2025								—		1,597		3,194								723,042
TSR PSUs (5)		3/7/2025		2/25/2025								—		1,597		3,194								1,043,496

(1)	On February 25, 2025, the HC Committee approved the stock options, PSUs and RSUs to be granted to NEOs. It set March 7, 2025 as the actual grant date for all award types. For a more detailed description of equity grant practices, see the CD&A under the caption “Equity Awards.”
(2)	The actual amount of performance-based variable compensation paid for 2025 performance is shown in the “Summary Compensation Table” under “Non-Equity Incentive Plan Compensation.” The amounts shown in these columns in the table above are the range of potential 2025 payments that could have been made. For more information, see the descriptions in the CD&A under the caption “Annual Performance-Based Variable Compensation.”
(3)	These are the number of shares underlying stock option grants made in March 2025. See the explanation set forth in the CD&A under the caption “Equity Awards” for more information.

54 Linde plc

Executive Compensation Matters

Executive Compensation Tables

(4)	This is the number of RSUs granted in March 2025. See the explanation set forth in the CD&A under the caption “Equity Awards” for more information.
(5)	These are the threshold, target and maximum number of shares that may be earned under PSU awards made in March 2025. See the explanation set forth in the CD&A under the caption “Equity Awards” for more information.
(6)	The amounts shown are the full grant date fair values of the RSU, PSU, and the stock option awards made in 2025, calculated in accordance with accounting standards related to share-based compensation. The values for the PSU awards are based on the target number of units granted. These amounts are neither paid to any NEO nor equal to the amounts recognized by the Company as compensation expense in 2025.

Linde plc 55

Executive Compensation Matters

Executive Compensation Tables

2025 Outstanding Equity Awards at Fiscal Year-End

The table below shows outstanding equity awards at the end of 2025. The material terms of the awards are described under the caption “Equity Awards” in the CD&A and in the footnotes to the table below. Treatment of equity awards upon termination of employment is described in the “Severance and Other Change-in-Control Benefits” section under the caption “Equity Awards.”

		Option Awards										Stock Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable (1)		Number of Securities Underlying Unexercised Options (#) Unexercisable (1)		Option Exercise Price ($)(2)		Option Grant Date		Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)(3)		Market Value of Shares or Units of Stock That Have Not Vested ($)(4)(5)		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(6)		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(4)
Sanjiv Lamba		15,470		—		176.63		3/20/2019		3/20/2029		19,784		8,435,700		58,832		25,085,376
		37,565		—		173.13		3/9/2020		3/8/2030
		40,995		—		253.68		3/8/2021		3/7/2031
		54,920		—		270.99		3/7/2022		3/5/2032
		30,910		15,455		354.14		3/7/2023		3/7/2033
		13,843		27,687		465.29		3/7/2024		3/7/2034
		—		44,696		468.77		3/7/2025		3/7/2035
Matthew J. White		72,795		—		118.71		2/28/2017		2/26/2027		8,223		3,506,205		24,391		10,400,078
		64,665		—		154.00		2/27/2018		2/25/2028
		47,020		—		176.63		3/20/2019		3/20/2029
		43,695		—		173.13		3/9/2020		3/8/2030
		34,320		—		253.68		3/8/2021		3/7/2031
		22,535		—		270.99		3/7/2022		3/5/2032
		12,646		6,324		354.14		3/7/2023		3/7/2033
		5,671		11,344		465.29		3/7/2024		3/7/2034
		—		19,156		468.77		3/7/2025		3/7/2035
Guillermo Bichara		26,980		—		176.63		3/20/2019		3/20/2029		4,863		2,073,535		14,399		6,139,590
		26,155		—		173.13		3/9/2020		3/8/2030
		20,975		—		253.68		3/8/2021		3/7/2031
		13,280		—		270.99		3/7/2022		3/5/2032
		7,390		3,695		354.14		3/7/2023		3/7/2033
		3,391		6,784		465.29		3/7/2024		3/7/2034
		—		11,326		468.77		3/7/2025		3/7/2035
Sean F. Durbin		7,045		—		173.13		3/9/2020		3/8/2030		4,631		1,974,612		13,707		5,844,528
		19,070		—		253.68		3/8/2021		3/7/2031
		12,395		—		270.99		3/7/2022		3/5/2032
		7,026		3,514		354.14		3/7/2023		3/7/2033
		3,203		6,407		465.29		3/7/2024		3/7/2034
		—		10,889		468.77		3/7/2025		3/7/2035
Benjamin W. Glazer		17,785		—		154.00		2/27/2018		2/25/2028		3,004		1,280,876		8,782		3,744,557
		9,745		—		176.63		3/20/2019		3/20/2029
		8,740		—		173.13		3/9/2020		3/8/2030
		6,390		—		253.68		3/8/2021		3/7/2031
		7,325		—		270.99		3/7/2022		3/5/2032
		4,216		2,109		354.14		3/7/2023		3/7/2033
		2,113		4,227		465.29		3/7/2024		3/7/2034
		—		7,468		468.77		3/7/2025		3/7/2035
David P. Strauss		7,545		—		154.00		2/27/2018		2/25/2028		3,803		1,621,561		11,231		4,788,786
		20,985		—		176.63		3/20/2019		3/20/2029
		20,870		—		173.13		3/9/2020		3/8/2030
		15,925		—		253.68		3/8/2021		3/7/2031
		10,200		—		270.99		3/7/2022		3/5/2032
		5,676		2,839		354.14		3/7/2023		3/7/2033
		2,670		5,340		465.29		3/7/2024		3/7/2034
		—		8,973		468.77		3/7/2025		3/7/2035

(1)	All listed stock option awards vest in three consecutive equal annual installments beginning on the first anniversary of their respective grant date.
(2)	The exercise price for all listed stock options with grant dates prior to 2024 is equal to the closing price on the New York Stock Exchange (NYSE) on the grant date. In late 2023, the Company’s common stock began trading on the Nasdaq Stock Market (Nasdaq) and the exercise price for the listed stock options with grant dates in 2024 and later is equal to the closing price on the Nasdaq on the grant date.
(3)	This column includes the number of shares underlying the RSU awards granted to the NEOs in March 2023, 2024 and 2025 Additional information is discussed in the CD&A under the caption “Equity Awards.”
(4)	The market value reported in this column is the number of unvested RSUs multiplied by the $426.39 December 31, 2025 closing price of the Company’s common stock as reported on the Nasdaq.
(5)	Where applicable under U.S. tax law, the Company collects from NEOs and pays Federal Insurance Contributions Act (FICA) taxes on awards.
(6)	This column includes the actual number of shares paid in settlement of the PSUs granted in March 2023, plus the target number of PSUs granted in March 2024 and 2025. The ROC-measured PSUs granted in 2023 vested at 189% of their target and the TSR-measured PSUs granted in 2023 vested at 100% of their target. These amounts were paid out in March 2026. See “Performance Share Unit Goals and Results” in the CD&A section of this Proxy Statement for more information.

56 Linde plc

Executive Compensation Matters

Executive Compensation Tables

2025 Option Exercises and Stock Vested

This table provides information about any stock options that were exercised and PSUs and RSUs that vested during 2025.

	Option Awards				Stock Awards
Name	Number of Shares Acquired on Exercise (#)		Value Realized on Exercise ($)(1)		Number of Shares Acquired on Vesting (#)(2)		Value Realized on Vesting ($)(2)
Sanjiv Lamba		—		—		36,991		17,340,271
Matthew J. White		—		—		15,184		7,117,804
Guillermo Bichara		—		—		8,959		4,199,710
Sean F. Durbin		7,795		2,184,081		8,351		3,914,698
Benjamin W. Glazer		—		—		4,939		2,315,255
David P. Strauss		7,545		2,383,805		6,881		3,225,606

(1)

The option value realized on exercise for 2025 equals (i) the Nasdaq market price of the Company’s common stock at the time of the option exercise minus the option exercise price, multiplied by (ii) the number of option shares exercised. All amounts reported are before taxes.

(2)

These values represent shares acquired pursuant to the vesting and payout in March 2025 of PSU and RSU awards that were granted in March 2022. At the achieved performance levels, the ROC PSUs granted in 2022 vested and were settled at 200% of target, and the TSR PSUs granted in 2022 vested and were settled at 184% of target. The value realized on vesting is before taxes and equals the number of shares paid out multiplied by the Nasdaq closing price of the Company’s common stock on the applicable vesting date.

Linde plc 57

Executive Compensation Matters

Executive Compensation Tables

2025 Pension Benefits

The table below shows certain retirement benefit information under the Company’s Pension Programs and agreements.

	Plan Name(1)	Number of Years of Credited Service (#)		Present Value of Accumulated Benefit ($)(2)		Payments During Last Fiscal Year ($)
Sanjiv Lamba	Linde Pension Obligation		15		5,004,656		—
	Linde U.S. Pension Plan		4		56,000		—
	Supplemental Retirement Income Plan		4		613,000		—
Matthew J. White	Linde U.S. Pension Plan		21		294,000		—
	Supplemental Retirement Income Plan		21		899,000		—
Guillermo Bichara (3)	Linde U.S. Pension Plan		19		190,000		—
	Supplemental Retirement Income Plan		19		606,000		—
Sean F. Durbin	Linde U.S. Pension Plan		34		328,000		—
	Supplemental Retirement Income Plan		34		384,000		—
Benjamin W. Glazer	Linde U.S. Pension Plan		23		282,000		—
	Supplemental Retirement Income Plan		23		274,000		—
David P. Strauss	Linde U.S. Pension Plan		26		1,392,000		—
	Supplemental Retirement Income Plan		26		6,380,000		—

(1)	Mr. Strauss participates in the Linde U.S. Pension Program’s Traditional Design component and Messrs. Lamba, White, Bichara, Durbin, and Glazer participate in the Linde U.S. Pension Program’s Account-Based Design Component. Mr. Lamba’s pension entitlements for his service through the end of 2021 are set out in an individual contract that is described in further detail under “Additional Information Regarding 2025 Pension Benefits Table.”. For benefits accruing for his service completed after 2021, Mr. Lamba participates in the Linde U.S. Pension Program’s Account-Based Design Component. Further details of the Company’s pension obligations for each NEO are included under “Additional Information Regarding 2025 Pension Benefit Table.”
(2)	See the narrative after the table for a description of the Present Value of Accumulated Benefit. The values for each plan listed above are additive.
(3)	In addition to the benefit he has accrued under the general terms of the Company’s Pension Program, the Supplemental Retirement Income Plan Present Value of Accumulated Benefit for Mr. Bichara reflects a one-time credit of $53,302.70 that was made on his behalf under a 2011 agreement with the Company in connection with the transfer of his employment to the U.S. from the Company’s Mexico affiliate. The contribution represents the benefit that he would have accrued under the Linde U.S. Pension Program’s Account-Based Design Component had his employment with the Company’s Mexico Affiliate from 2006 through 2011 been included as eligible service under the U.S. Pension Program. This amount vested in 2013 and accrues interest credits annually in the same manner and at the same rate as other benefits under the Pension Program’s Account-Based Design Component.

58 Linde plc

Executive Compensation Matters

Executive Compensation Tables

Additional Information Regarding 2025 Pension Benefits Table

Present Value of Accumulated Benefit

The 2025 Pension Benefits table includes a “Present Value of Accumulated Benefit.” This is the value in today’s dollars of the total expected future retirement benefits that each NEO may receive under the Pension Program and their prior contract, if applicable. These are accrued amounts as of the end of 2025.

For any given year, there will be a change in the accumulated benefit. For example, from one year to the next, the accumulated benefit may increase because a NEO has worked for an additional year and received credit for that or their pensionable earnings have increased. The accumulated benefit may also increase or decrease based on the interest rate used to calculate the present value of the NEO’s retirement payments compared to the prior year.

The annual change in accumulated benefit is disclosed in the “Summary Compensation Table” in the “Change in Pension Value” column.

The Company recognizes these amounts as a future pension liability on its financial statements. The Company calculates these amounts using complex actuarial valuations and assumptions. These assumptions are described in Note 16 to the Company’s 2025 financial statements in the 2025 Form 10-K and Annual Report. However, as required by SEC rules, the 2025 Pension Benefits table assumes that each NEO will retire at the earliest retirement age that would provide full (unreduced) benefits. The value in today’s dollars of the total retirement benefits that each NEO eventually receives may be more or less than the amount shown in the 2025 Pension Benefits table.

General Terms of the Linde U.S. Pension Program

Except as otherwise noted, the NEOs participate in the same pension program maintained for other eligible U.S. employees of the Company (the “Pension Program”). The Company has an obligation to pay pension benefits according to formulas described below. The Pension Program does not include the Company’s U.S. 401(k) Plan. The 401(k) Plan is funded by employee and Company contributions, but the Company does not promise any given retirement benefit. Instead, any retirement payments will depend on employee and Company contributions and the investment return on those contributions.

The Pension Program has the following two parts:

1. The Linde U.S. Pension Plan (the “Pension Plan”) is intended to meet Federal tax law rules so that it will be considered a “tax-qualified” defined benefit retirement plan. Applicable laws require the Company to periodically set aside funds to meet its obligations under this plan. The rules also limit the amount of benefits that can be paid and do not allow using pay above certain levels to calculate retirement benefits. One or more of these limitations apply to each NEO and to certain other employees. Therefore, the Company also maintains “non-qualified” supplemental plans.

2. The Linde Inc. Equalization Benefit and Supplemental Retirement Income Plans (collectively referred to as the “SRIP”) are non-qualified deferred compensation plans under U.S. tax rules. Therefore, the Company does not set aside funds to meet these plan obligations. Instead, SRIP participants have only the Company’s promise to pay the amounts due following their separation from service with the Company. The terms of the SRIP are largely the same as those of the Pension Plan except that: (i) benefits payable under the SRIP are not limited by the Federal tax law limits, (ii) in order to comply with Federal tax law governing non-qualified deferred compensation plans, benefits accrued under the SRIP are payable at different times and in different forms than those payable under the Pension Plan, and (iii) NEOs may have additional benefits paid under the SRIP that are not the same as the standard benefits of the Pension Plan (see Note 3 following the “2025 Pension Benefits” table regarding a preexisting agreement for Mr. Bichara).

Benefits under the Pension Program are calculated under one of the following two basic designs:

Linde plc 59

Executive Compensation Matters

Executive Compensation Tables

Traditional Design (Applicable to Mr. Strauss)

· The Traditional Design program is applicable only to eligible U.S. employees who were hired by legacy Praxair, Inc. prior to May 1, 2002 and previously elected to continue coverage in the Traditional Design. This benefit formula considers an employee’s final average pay and years of service with the Company. For this purpose, the employee’s “final average pay” is generally equal to the employee’s highest three years of salary plus annual variable compensation out of their last ten years of service.

· Generally, an employee’s annual pension benefit is determined using a formula of 1.5% times the employee’s years of service with the Company times the employee’s final average pay. This is subject to several reductions, including offsets for the employee’s projected Social Security benefits and certain pension benefits payable under pension programs maintained by the Company’s subsidiaries or affiliates.

· Unreduced pension benefits are generally payable from the Pension Plan in an annuity beginning following the employee’s separation from service after the earliest of (i) the employee’s reaching age 65, (ii) the employee’s reaching age 62 and completing at least 10 years of service with the Company, or (iii) when the sum of the employee’s age plus years of service with the Company equals at least 85. Mr. Strauss is eligible to immediately commence an unreduced pension benefit following his separation from service and has previously announced his retirement from employment with the Company, effective as of March 31, 2026.

· Traditional Design benefits under the SRIP are generally payable in a lump sum following the employee’s separation from service with the Company with the lump sum payment being actuarially equivalent to the employee’s accrued benefit under the SRIP determined using actuarial factors set forth in the Pension Program.

· Traditional Design SRIP benefits become immediately vested and payable in a lump sum upon the occurrence of a change-in-control of the

Company (as defined in the SRIP) unless the NEO has made a valid election to waive the right to receive an accelerated payment of their SRIP benefit in connection with a change-in-control and to instead receive such payment in the ordinary course.

Account-Based Design (Applicable to Messrs. Lamba, White, Bichara, Durbin, and Glazer)

· This is a “cash balance” pension design that applies to eligible U.S. employees of the Company who are not covered under the Traditional Design program. The Company makes an annual notional “contribution” for each participant equal to 4% of eligible pay (salary plus annual variable compensation) and credits each participant’s account with interest annually based on the 30-year Treasury Bond rate in effect during the preceding October.

· Benefits vest upon the employee’s completion of three years of service and are generally payable in an annuity form or, if elected by the participant, in a lump sum, beginning any time after the participant’s termination of employment.

· Account-based benefits under the SRIP are payable in a single lump sum following the employee’s separation from service and become immediately vested and payable upon the occurrence of a change-in-control of the Company (as defined in the SRIP) unless the NEO has made a valid election to waive the right to receive an accelerated payment of their SRIP benefit in connection with a change-in-control and to instead receive such payment in the ordinary course.

· Mr. Lamba has been a U.S. employee since January 1, 2022 and began accruing pension benefits under the Pension Program’s Account-Based Design at that time.

60 Linde plc

Executive Compensation Matters

Executive Compensation Tables

Linde Pension Commitments Applicable to Mr. Lamba for Service Prior to 2022

In addition to the benefits that he began accruing in 2022 under the U.S. Pension Program’s Account-Based Design, Mr. Lamba is entitled to pension benefits in connection with his service with Linde completed prior to 2022. These benefits are provided pursuant to an agreement between him and an affiliate of the Company. Following his retirement from service with the Company upon or after attaining age 65, Mr. Lamba is eligible to receive a monthly benefit for life equal to €20,227, subject to an annual adjustment to reflect changes in the consumer price index. In the event Mr. Lamba terminates employment with the Company prior to attaining age 65, including on account of his disability, he is eligible to commence payment of a reduced

benefit. In the event of Mr. Lamba’s death, a benefit equal to 60% of the benefit he was receiving or, in the event his death prior to his commencement, the amount he would have received, is payable to his surviving spouse, and an additional benefit is payable to each of his of children until they attain age 18 or for as long as the child remains a student, through age 26. The benefit payable to each child is either 10% or 25% of Mr. Lamba’s benefit depending upon whether the child’s other parent remains alive. The collective benefit payable to all of Mr. Lamba’s children may not exceed 50% of his benefit and the aggregate benefits payable to his surviving spouse and children collectively, may not exceed 100% of his benefit.

Linde plc 61

Executive Compensation Matters

Executive Compensation Tables

2025 Nonqualified Deferred Compensation

This table shows information regarding compensation amounts, if any, that (i) the NEOs decided not to receive in cash but elected to defer to a later date under the U.S. Linde Compensation Deferral Program, or (ii) are Company contributions to the Compensation Deferral Program.

Name	Executive Contributions in Last Fiscal Year ($)		Company Contributions in Last Fiscal Year ($)(1)		Aggregate Earnings in Last Fiscal Year ($)		Aggregate Withdrawals/ Distributions ($) (2)		Aggregate Balance at Last Fiscal Year End ($)(3)
Sanjiv Lamba		—		61,250		2,771		—		236,812
Matthew J. White		—		29,738		18,197		—		659,345
Guillermo Bichara		—		24,013		9,507		—		365,072
Sean F. Durbin		—		21,950		3,607		—		168,186
Benjamin W. Glazer		—		13,750		2,621		—		116,742
David P. Strauss		—		13,960		165,731		1,162,417		3,672,884

(1)The amount shown are the Company contributions for NEOs made in 2026 for 2025. These amounts are included in “All Other Compensation” in the “Summary Compensation Table.” Also, see the further explanation under the caption “Material Terms of the U.S. Compensation Deferral Program.”

(2)The amount shown represents a cash payout to Mr. Strauss in January 2025 for the portion of his 2021 variable compensation award that he previously elected to defer.

(3)Balances are net of prior payouts and otherwise are the total of (i) all compensation that each NEO previously elected to defer, (ii) Company contributions made to the U.S. Compensation Deferral Program on behalf of each NEO, and (iii) any notional investment earnings on these amounts. The balances were not amounts paid in 2025.

Material Terms of the U.S. Compensation Deferral Program

Deferral Elections; Company Contributions

Eligible senior employees on the Company’s U.S. payroll, including NEOs, may elect to defer receipt of all or a portion of their annual variable compensation payments and/or base salaries, subject to limitations to ensure that sufficient un-deferred pay remains available to cover applicable withholding taxes and benefit premiums.

In addition, the Company makes a notional contribution to the Compensation Deferral Program on behalf of each eligible NEO equal to the matching contributions that

would have been made under the Company’s U.S. 401(k) plan on behalf of the NEO but for the application of certain U.S. Federal tax law limits under that plan.

The Company does not fund or segregate any monies from its general funds, create any trusts, or make any special deposits for payment of benefits under the Compensation Deferral Program. A participant’s right to receive a payment under the Compensation Deferral Program is no greater than the right of an unsecured general creditor of the Company.

62 Linde plc

Executive Compensation Matters

Executive Compensation Tables

Deferral Investments

Participants may notionally invest their deferred compensation into either (1) the Linde plc stock-unit equivalent account whose value tracks the market value of Linde common stock, including reinvestment of dividends into additional Linde stock-equivalent units, or (2) a fixed income account whose interest rate is fixed

annually and is equal to the 1-year U.S. Treasury Bond rate as of the end of the immediately preceding year, plus 50 basis points. All Company contributions are made into the Linde plc stock-unit equivalent account. No preferential earnings are paid to participants, including NEOs.

Deferral Payouts

When a deferral election is made, a participant elects to receive payment in either a lump sum or substantially equal installments over ten years following termination of employment or a specified later year. Payment is accelerated in the case of the participant’s death. Company contributions are paid out in a lump sum upon retirement or other separation from service.

If a change-in-control of the Company (as defined in the U.S. Compensation Deferral Program) occurs, all previously deferred amounts will be paid unless elected otherwise by the NEO.

Severance and Other Change-In-Control Benefits

The severance and other change-in-control benefits available to each of the NEOs are described below. The benefits applicable to each NEO depend on the programs in which they participate and the contractual obligations between Linde and the NEO, if any.

The Company has not entered into any individual agreements with any NEO that would obligate it to pay post-employment severance benefits, including in connection with a change-in-control of the Company. Rather, the Company maintains a U.S. Severance Plan that provides certain benefits to all eligible U.S. employees, including the NEOs, in connection with certain Company-initiated terminations.
Under the U.S. Severance Plan and other programs:
·	No severance payout and forfeiture of unvested equity awards and vested unexercised stock options are required upon a for-cause termination.

· Upon a without-cause termination, the maximum severance benefit is generally limited to 26 weeks of base pay, dependent upon length of service at time of termination, and is conditioned upon the employee’s general release of all claims against the Company.

· The Company retains discretion to provide additional severance benefits.

General Assumptions

The table below shows the estimated payments and/or benefits in connection with the following events based upon the following assumptions.

“Voluntary Termination,” which includes a NEO’s voluntary resignation, before or after meeting specified age and service requirements, and “Involuntary-for-Cause Termination,” which includes the Company’s termination of a NEO’s employment for reasons such as violation of certain Company policies or for certain performance-related issues.

For purposes of this section, the specified “age and service” requirements are generally satisfied if a NEO terminates employment with the Company other than for cause after both (a) attaining age 55 (age 62 for awards made before 2019), and (b) completing at least 10 years of service.

“Involuntary Termination,” which includes a termination other than for cause, but not including a termination related to a change-in-control of the Company. Terminations due to death or disability result in substantially the same treatment as an Involuntary Termination, except as otherwise described.

A “Change-in-Control” of the Company, as defined under the plans and agreements described below.

Linde plc 63

Executive Compensation Matters

Severance and Other Change-In-Control Benefits

Generally, under these plans and agreements, a “change-in-control” means, (1) any consolidation or merger in which the Company is not the continuing or surviving corporation; (2) the liquidation of the Company or the sale of all or substantially all of the assets of the Company; (3) an acquisition by a person or group of more than 20% of the Company’s outstanding shares; or (4) a change in the majority composition of the Board not approved by two-thirds of the directors in office before the change.

Set forth below after the table are narrative descriptions of payments and/or benefits that would have been provided, if any, related to each employment termination event or a change-in-control, as of December 31, 2025.

Also discussed is the basis upon which the payments and/or benefits were calculated. Except as noted, these amounts are the incremental or enhanced amounts that a NEO would have received that are greater than those that the Company would have provided to employees generally under the same circumstances. They are estimates only and are based on various assumptions. The actual amounts that would be paid or the benefits that would be provided can be determined only at the time that each event occurs.

The table and the narrative discussion assume that (i) each NEO’s employment terminated on December 31, 2025 due in turn to each termination event; (ii) a change-in-control occurred on December 31, 2025 under the terms of various plans and agreements, regardless of a termination of employment, and (iii) values related to outstanding stock awards reflect the market value of the Company’s common stock of $426.39 per share, which was the closing price on the Nasdaq as of December 31, 2025.

64 Linde plc

Executive Compensation Matters

Severance and Other Change-In-Control Benefits

2025 Amounts Potentially Payable Upon Termination

Name	Termination Event	Severance Benefits ($)		Other Post- Termination Benefits ($)		Deferred Compensation Payout ($)		Performance- Based Variable Compensation Payments ($)		Equity Awards ($)		Retirement Benefit Enhancements ($)		Reduction of Payments ($)		Total for Each Termination Event
Sanjiv Lamba	Voluntary or Involuntary for Cause		—		—		—		—		—		—		—		—
	Involuntary		—		—		—		—		23,096,175		—		—		23,096,175
	Change-in-Control		—		—		—		—		34,637,700		—		—		34,637,700
Matthew J. White	Voluntary or Involuntary for Cause		—		—		—		—		—		—		—		—
	Involuntary		—		—		—		—		9,502,773		—		—		9,502,773
	Change-in-Control		—		—		—		—		14,363,192		—		—		14,363,192
Guillermo Bichara	Voluntary or Involuntary for Cause		—		—		—		—		—		—		—		—
	Involuntary		—		—		—		—		5,598,118		—		—		5,598,118
	Change-in-Control		—		—		—		—		8,480,088		—		—		8,480,088
Sean F. Durbin	Voluntary or Involuntary for Cause		—		—		—		—		—		—		—		—
	Involuntary		—		—		—		—		5,318,973		—		—		5,318,973
	Change-in-Control		—		—		—		—		8,073,026		—		—		8,073,026
Benjamin W. Glazer	Voluntary or Involuntary for Cause		—		—		—		—		—		—		—		—
	Involuntary		—		—		—		—		3,327,275		—		—		3,327,275
	Change-in-Control		—		—		—		—		5,177,808		—		—		5,177,808
David P. Strauss	Voluntary or Involuntary for Cause		—		—		—		—		—		—		—		—
	Involuntary		—		—		—		—		4,341,527		—		—		4,341,527
	Change-in-Control		—		—		—		—		6,615,465		—		—		6,615,465

Severance Benefits

Involuntary Termination. The NEOs are eligible for severance benefits which are determined in the same manner as for all other eligible U.S. employees of the Company, as described previously.

Change-in-Control. No NEO is entitled to any additional severance benefits on account of the termination of their employment in connection with a change-in-control.

Other Post-Termination Benefits

The Company currently makes retiree medical benefits available to eligible U.S. employees who participate in the Pension Program’s Traditional Design, including Mr. Strauss, provided that they meet certain requirements at the time of their termination. There are no other post-termination benefits to be provided to Messrs. Lamba, White, Bichara, Durbin or Glazer.

Linde plc 65

Executive Compensation Matters

Severance and Other Change-In-Control Benefits

Deferred Compensation Payout

Each NEO’s accrued balance in their U.S. Linde Compensation Deferral Program account, if any, is payable in accordance with program terms, as described under the “Nonqualified Deferred Compensation” table.

Change-in-Control. Under the U.S. Linde Compensation Deferral Program, the payout of deferred balances is accelerated upon a change-in-control unless the NEO has previously made a valid election to waive rights to receive an accelerated payment in connection with the change-in-control, and instead, to receive payment in accordance with their previous election.

Annual Performance-Based Variable Compensation Payments

Annual performance-based variable compensation awards that NEOs may receive are entirely at the discretion of the HC Committee. It is speculative whether the HC Committee would have made such awards for 2025 if a NEO’s employment terminated.

If an award had been made for the 2025 calendar year, it would have been fully earned at December 31, 2025.

Equity Awards

The following table summarizes the treatment of unvested equity awards in the event of a Voluntary Termination, Involuntary Termination, or a Change-in-Control.

	Voluntary	For Cause	Death	Disability	Change-in-Control
Stock options	Immediately forfeited but will continue to vest in the ordinary course if NEO terminates after the first anniversary of the grant date and satisfied the specified age and service requirements prior to termination	Immediately forfeited	Immediately vest in  full	Immediately vest in full	No accelerated vesting unless the NEO’s employment is terminated by the acquirer without cause or by the NEO for good reason, in either case within two years following the Change-in-Control (“Double Trigger”)
RSUs	Immediately forfeited but will immediately vest with settlement on the third anniversary of the grant date if NEO terminates after the first anniversary of the grant date and satisfied the specified age and service requirements prior to termination	Immediately forfeited	Pro rata portion vests immediately	Pro rata portion vests immediately	No accelerated vesting unless Double Trigger occurs
PSUs	Immediately forfeited but will continue to vest in the ordinary course, subject to satisfaction of the applicable performance criteria if NEO terminates after the first anniversary of the grant date and satisfied the specified age and service requirements prior to termination	Immediately forfeited	Pro rata portion (based on target number of shares granted) vests immediately	Pro rata portion (based on target number of shares granted) vests immediately	Awards convert to RSUs based on the higher of the target number of shares granted and the number of shares determined from actual performance up to the Change-in-Control; no accelerated vesting unless Double Trigger occurs

66 Linde plc

Executive Compensation Matters

Severance and Other Change-In-Control Benefits

For purposes of this disclosure, values are attributed solely to the acceleration of vesting of outstanding awards. To the extent that accelerated vesting occurs as described previously, the option acceleration value shown in the table on page 65 is determined by the difference between the exercise price of the accelerated options and the per share price of the Company’s common stock times the number of the accelerated option shares. The acceleration values of the RSU and PSU awards is determined as the per share price of the Company’s common stock times the number of shares subject to the award (target number of shares for PSUs).

Retirement Benefit Enhancements

The Pension Program and contractual pension entitlements for each NEO are discussed as part of the “2025 Pension Benefits” table. Except as discussed below, no enhanced pension benefits would be payable to any NEO that are not otherwise included in the 2025 Pension Benefits table.

Voluntary Termination, Involuntary-for-Cause Termination, and Involuntary Termination. Messrs. White, Bichara, Durbin, Glazer, and Strauss would not be entitled to any additional or enhanced benefit under these termination events, but any vested benefit would be preserved and would become payable under the Pension Program at such time as the NEOs would otherwise become eligible for pension payments.

Pursuant to his earlier agreement with an affiliate of the Company, in the event that Mr. Lamba terminates

employment due to death, disability, or his involuntary termination other than for cause, he or his beneficiary, as applicable, is entitled to certain retirement benefit enhancements. The amount shown in the table, reflect the values of these benefit enhancements.

Change-in-Control. Benefits under the SRIP become immediately vested and payable in a lump sum upon the occurrence of a change in control unless the NEO has previously made a valid election to waive rights to receive such payment in connection with the change-in-control and to instead receive such payment in the ordinary course. There is no value calculated for any acceleration as each NEO is already fully vested in their SRIP benefit and would simply receive payment sooner than if a change in control had not occurred.

Mr. Lamba is not entitled to any additional retirement benefit enhancements in connection with a change-in-control. However, if his employment was terminated following a change-in-control, the enhanced retirement benefits due under his agreement in connection with his termination other than for cause would apply. This value is shown in the table.

No Excise Tax Gross-Up Payments

The Company has no agreements in place that require it to reimburse any NEO for excise or other taxes they may owe under Section 4999 of the Internal Revenue Code or otherwise due to their receipt of excess “parachute” payments in connection with a change-in-control.

Linde plc 67

Executive Compensation Matters

Pay versus Performance

Pay versus Performance

Pay Versus Performance Table

The table and related graphs below disclose the relationship of (i) compensation for the CEO and other NEOs and (ii) Company performance as defined by, and required under, Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and related SEC rules for the years ended December 31, 2025, 2024, 2023, 2022, and 2021. For further information concerning the Company’s variable pay-for-performance philosophy and how the Company aligns executive compensation with its performance, refer to the CD&A.

													Value of Initial Fixed $100 Investment Based on:
Year	Summary Compensation Table Total for First CEO (1)		Summary Compensation Table Total for Second CEO (2)		Compensation Actually Paid to First CEO (3) (4)		Compensation Actually Paid to Second CEO (3) (4)		Average Summary Compensation Table Total for non-CEO NEOs (5)		Average Compensation Actually Paid to non-CEO NEOs (3) (4)		Total Shareholder Return		Peer Group Total Shareholder Return (6)		Net Income ($millions)		After-Tax Return on Capital (7)
2025		N/A		21,777,870		N/A		15,934,321		6,318,470		4,707,380		$173.35		$138.87		6,898		24.2%
2024		N/A		20,696,088		N/A		29,105,314		6,317,157		11,370,874		$167.96		$125.63		6,565		25.9%
2023		N/A		19,200,255		N/A		37,797,969		6,915,460		15,410,187		$162.78		$125.68		6,199		25.4%
2022		362,539		14,601,322		11,788,827		24,588,666		5,043,958		8,752,653		$127.51		$111.66		4,147		22.9%
2021		31,426,032		N/A		60,017,000		N/A		8,514,019		15,425,165		$133.38		$127.28		3,826		17.7%

(1)Amounts reported in this column and others related to the “First CEO” are for Stephen F. Angel, who served as Chief Executive Officer of the Company until his retirement from employment in March 2022.

(2)Amounts reported in this column and others related to the “Second CEO” are for Sanjiv Lamba, who succeeded Mr. Angel as Chief Executive Officer of the Company upon Mr. Angel’s retirement.

(3)The dollar amounts do not reflect the actual amounts of compensation paid to the Company’s CEO and other NEOs in each applicable year, but rather represent the amount of “compensation actually paid” as defined by the SEC rules, which includes: (1) the year-end value of equity awards granted in each applicable year, (2) the change in value of equity awards that were unvested at the end of the prior year, measured through the date the awards vested or through the end of the reported calendar year, and (3) certain pension-related costs.

The calculation of equity award values described above required that the awards be measured as of each vesting date or year-end, as applicable, using certain assumptions. For ROC-measured PSUs and RSUs, the fair values are based on the closing market price of Linde’s ordinary shares on each valuation date adjusted for dividends that were not paid during the remaining vesting period, if any. For relative TSR-measured PSUs, the fair values are based on Monte Carlo simulations performed as of each valuation date. Footnote 8 contains a table summarizing the relevant Monte Carlo modeling inputs associated with each award/valuation date for the 2025 calculation.

The Company utilizes the Black-Scholes Option-Pricing Model to determine the fair value of stock options. Management is required to make certain assumptions with respect to selected model inputs, including anticipated changes in the underlying stock price (i.e., expected volatility) and option exercise activity (i.e., expected life). Expected volatility is based on the historical volatility of the Company’s stock over the most recent period commensurate with the estimated expected life of the Company’s stock options and other factors. The expected life of options is based primarily on historical exercise experience. The expected dividend yield is based on the Company’s most recent history and expectation of dividend payouts. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of valuation for a period commensurate with the estimated expected life. Footnote 9 contains a table summarizing the weighted-average assumptions that were used to value the stock option awards for the 2025 calculation.

68 Linde plc

Executive Compensation Matters

Pay versus Performance

(4)Deductions from, and additions to, total compensation in the Summary Compensation Table by year to calculate Compensation Actually Paid consist of:

	2025
	CEO				Average Non- CEO NEOs
Total Compensation from Summary Compensation Table		$	21,777,870			$	6,318,470
Adjustments for Pension
Adjustment for Aggregate Change in Actuarial Present Value of Pension		$	(198,000	)		$	(158,200	)
Amount added for current year service cost		$	158,949			$	74,447
Total Adjustments for Pension		$	(39,051	)		$	(83,753	)
Adjustments for Equity Awards
Adjustment for grant date values in the Summary Compensation Table		$	(16,619,712	)		$	(4,299,932	)
Year-end fair value of unvested awards granted in the current year		$	10,294,253			$	2,663,426
Year-over-year difference of year-end fair values for unvested awards granted in prior years		$	(3,869,426	)		$	(1,095,506	)
Difference in fair values between prior year-end fair values and vest date fair values for awards granted in prior years		$	4,390,386			$	1,204,675
Total Adjustments for Equity Awards		$	(5,804,498	)		$	(1,527,337	)
Compensation Actually Paid (as calculated)		$	15,934,321			$	4,707,380

(5)Amounts reported in this column and others related to the non-CEO NEOs are for: Matthew J. White, Sean F. Durbin, Guillermo Bichara, David P. Strauss, and Benjamin W. Glazer in 2025; Matthew J. White, Sean F. Durbin, Guillermo Bichara, and David P. Strauss in 2024; Matthew J. White, John M. Panikar, Sean F. Durbin, and Guillermo Bichara in 2023 and 2022; and Sanjiv Lamba, Matthew J. White, John M. Panikar, and Sean F. Durbin in 2021.

(6)Figures reported in this column are for peers in the Standard & Poor’s S5 Materials Index (“S5MATR”) which covers 28 companies, including Linde, consistent with the peer group used by the Company for purposes of Item 201(e) of Regulation S-K.

(7)Adjusted after-tax return on capital is a non-GAAP measure. Please see “ Reconciliation to Compensation and Non-GAAP Measures” on page 75 for a reconciliation to the reported GAAP amounts that are most comparable. While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance under the Company’s compensation programs, the Company has determined that adjusted after-tax return on capital is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link compensation actually paid to the NEOs, for the most recently completed fiscal year, to Company performance.

(8)Below is a table summarizing the relevant Monte Carlo modeling inputs associated with each award/valuation date for purposes of calculating the Compensation Actually Paid to the CEO and other NEOs in 2025.

Grant date	3/7/2024						3/7/2025
Valuation date	12/31/2024			12/31/2025			12/31/2025
Remaining perf. period (yrs.)			2			1			2
Valuation date price		$	418.67		$	426.39		$	426.39